Yayınlar & Eserler

Yayın Ağı
Makaleler 250
Tümü (250)
SCI-E, SSCI, AHCI (235)
SCI-E, SSCI, AHCI, ESCI (244)
ESCI (8)
Scopus (243)
TRDizin (9)
Diğer Yayınlar (3)

1. Inflammation at the Crossroads: Familial Mediterranean Fever and Cardiovascular Risk

Karup S., BAŞPINAR Ş. N., Ayci B., Azman Tunc F. N., Akyel A., Guler Y., et al.
Mediterranean Journal of Rheumatology , cilt.37, sa.2, ss.415-420, 2026 (ESCI, Scopus)

2. Pregnancy and Lactation Outcomes of Women With Rheumatic Diseases Treated With Certolizumab Pegol: Real-World Experience From a Tertiary Center

Acar B., Aktas B., Ayla A. Y., Eren H., Alkan A., UĞURLU S.
International Journal of Rheumatic Diseases , cilt.29, sa.6, 2026 (SCI-Expanded, Scopus)

3. Urological manifestations in familial Mediterranean fever excluding renal amyloidosis: a systematic review

Ozcan A. K., Karaoglan B., Gundogdu B., Sahin C., Simsekoglu M. F., UĞURLU S.
Rheumatology , cilt.65, sa.5, 2026 (SCI-Expanded, Scopus)

4. Machine-learning algorithms for predicting colchicine resistance in Familial Mediterranean Fever

Ozturk A., KILIÇ B., KUCUR M., Yagci L., UĞURLU S.
Rheumatology , cilt.65, sa.3, 2026 (SCI-Expanded, Scopus)

5. Can Colchicine Be a Therapeutic Option for Patients With Ankylosing Spondylitis?

Ates M. B., Egeli B. H., UĞURLU S.
International Journal of Rheumatic Diseases , cilt.29, sa.3, 2026 (SCI-Expanded, Scopus)

6. Colchicine discontinuation in familial Mediterranean fever: short-term outcomes by pre-discontinuation attack frequency

Aktas B., Parlar K., Senturk B., Saglam A., Dundar A., Uc C., et al.
Clinical Rheumatology , cilt.45, sa.2, ss.1257-1265, 2026 (SCI-Expanded, Scopus)

7. Efficacy and tolerability of switching from coated to compressed colchicine preparations in patients with Behçet’s syndrome

Fidan S., ESATOĞLU S. N., ÖZGÜLER Y., UĞURLU S., SEYAHİ E., MELİKOĞLU M., et al.
Rheumatology , cilt.65, sa.2, 2026 (SCI-Expanded, Scopus)

8. Familial Mediterranean Fever: A Comprehensive Review of Pathogenesis, Genetics, and Epigenetic Regulation

Uğurlu S., Kilinc O. C., Karacan İ., Parlar K.
Balkan Medical Journal , cilt.43, sa.1, ss.3-14, 2026 (SCI-Expanded, Scopus, TRDizin)

9. Impact of MEFV gene variants on clinical presentation in Familial Mediterranean Fever: A focus on Exon 2 mutations Impacto de las variantes del gen MEFV en la presentación clínica de la fiebre mediterránea familiar: enfoque en las mutaciones del exón 2

Kulaksiz B., Acar B., Kizilkaya O. O., Aktas B., UĞURLU S.
Reumatologia Clinica , cilt.22, sa.1, 2026 (ESCI, Scopus)

10. Treatment outcomes and predictors of macrophage activation syndrome in adult-onset Still’s disease: a 24 year single-centre experience

Acar B., Kizilkaya O., Aktas B., Kılınc O., UĞURLU S.
Scandinavian Journal of Rheumatology , 2026 (SCI-Expanded, Scopus)

11. Long-term echocardiographic findings in patients with idiopathic recurrent pericarditis treated with anakinra

Toker Dincer Z., Raimoglou D., YILMAZ B. E., Dag A., MELİKOĞLU M., UĞURLU S.
Internal Medicine Journal , 2026 (SCI-Expanded, Scopus)

12. Use of anakinra during pregnancy and breastfeeding in women with recurrent pericarditis: a case series

Moda F., Trotta L., Mascolo R., Mardygan V., Cercek A. C., Claveau A. M., et al.
EUROPEAN HEART JOURNAL , cilt.46, 2025 (SCI-Expanded, Scopus)

13. Clinical significance of non-infectious increased procalcitonin in Still's disease: A predictor of macrophage activation syndrome

Bektas E., ULUDOĞAN B. C., FIRLATAN YAZGAN B., Kilinc O. C., Acar B., Kizilkaya O. O., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.77, ss.1517-1519, 2025 (SCI-Expanded, Scopus)

14. Can Large Language Models Support Clinical Decision-Making in Atypical SLE? A Comparative Analysis

Acar B., Aktas B., Kizilkaya O. O., KUTLUBAY Z., UĞURLU S.
ARTHRITIS & RHEUMATOLOGY , cilt.77, ss.2888-2890, 2025 (SCI-Expanded, Scopus)

15. Interim Results of a Randomized Placebo Controlled Study of IL-1 Inhibitor Goflikicept in Patients With Familial Mediterranean Fever

Uhanova O., UĞURLU S., Kostik M., Sarkisyan T., Yeghiazaryan A., Lysenko L., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.77, ss.1519-1521, 2025 (SCI-Expanded, Scopus)

16. Pregnancy Outcomes in Women with Familial Mediterranean Fever Treated with Anakinra: A Retrospective Study

Ergezen B., Kilinc O. C., Egeli B., Kizilkaya O. O., PARLAR K., Azman E., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.77, ss.2297-2298, 2025 (SCI-Expanded, Scopus)

17. Certolizumab in Axial Spondyloarthritis: Persistence and Determinants

Aktas B., Azman E., Yüksel H. M., Erdogan B., Parlar K., Uc C., et al.
International Journal of Rheumatic Diseases , cilt.28, sa.6, 2025 (SCI-Expanded, Scopus)

18. Clinical characteristics and genetics of familial Mediterranean fever (FMF) in diverse populations: A comparative study of Italy, Turkey, and Lebanon

Jaber N., Kilic B., Yagci L., Ozturk A., Giordano V., Abdallah H., et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION , cilt.55, 2025 (SCI-Expanded, Scopus)

19. Emerging treatment approaches for VEXAS syndrome: a systematic review and meta-analysis

KILIÇ B., Sacin E., Tanin M. K., Kilinc O. C., UĞURLU S.
Annals of Hematology , cilt.104, sa.5, ss.2617-2630, 2025 (SCI-Expanded, Scopus)

20. De novo manifestations during adalimumab treatment in Behçet's syndrome

ESATOĞLU S. N., SÖNMEZ Ö., UÇAR D., Kaymaz E., ÖZGÜLER Y., UĞURLU S., et al.
RHEUMATOLOGY , cilt.64, sa.4, ss.2034-2040, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

21. Fertility in male patients with familial Mediterranean fever and paternal effect of FMF on pregnancy outcomes and complications

Parlar K., Azman F. N., Sıcakyüz S. L., Rızaoğlu M., Azman E., Yüzbaşıoğlu M. B., et al.
Internal and Emergency Medicine , cilt.20, sa.3, ss.797-803, 2025 (SCI-Expanded, Scopus)

22. Rare C1q deficiency presenting as pediatric SLE: A case study of two consanguineous siblings

Parlar K., Aktaş B., Sicakyüz S. L., Şahin S., KASAPÇOPUR Ö., UĞURLU S.
REUMATOLOGIA CLINICA , cilt.21, sa.3, 2025 (ESCI, Scopus) Sürdürülebilir Kalkınma

23. Rituximab intervention in management of thrombocytopenia in patients with systemic lupus erythematosus: A single centre experience

Toker Dincer Z., Acar B., Ersoy Y., Karali O., Azman F. N., Ammar T., et al.
Lupus , cilt.34, sa.3, ss.253-260, 2025 (SCI-Expanded, Scopus)

24. Fertility, pregnancy outcomes, and disease activity during pregnancy in patients with juvenile idiopathic arthritis: a descriptive study

Sonkurt A. I., Dogan G., Parlar K., Guler B., DEVECİ M., KASAPÇOPUR Ö., et al.
CLINICAL RHEUMATOLOGY , cilt.44, ss.789-797, 2025 (SCI-Expanded, Scopus)

25. Anakinra in the management of adult-onset still's disease: a single-center experience

Kilic B., Parlar K., Karup S., Ozturk A., Karaahmetli K., UĞURLU S.
INTERNAL AND EMERGENCY MEDICINE , cilt.20, sa.1, ss.131-138, 2025 (SCI-Expanded, Scopus)

26. A rare case of late-onset spondyloenchondrodysplasia with immune dysregulation presenting as adult-onset monogenic lupus

Firat Senturk E., Ayvaz B. B., FIRTINA S., UĞURLU S.
Lupus , cilt.34, sa.1, ss.108-114, 2025 (SCI-Expanded, Scopus)

27. VEXAS Syndrome: An Overlooked Threat

UĞURLU S., KILIÇ B.
Balkan Medical Journal , cilt.42, sa.3, ss.185-187, 2025 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

28. Mimics and challenging presentations of DADA2

Öztürk A., Yagci L., UĞURLU S.
Clinical and Experimental Immunology , cilt.219, sa.1, 2025 (SCI-Expanded, Scopus)

29. Rituximab Treatment in Lupus Nephritis Resistant to Conventional Therapy: A Single-Centre Experience

Senturk E. F., Ogun H., DURUCAN İ., Yurttas B., UĞURLU S.
Mediterranean Journal of Rheumatology , cilt.36, sa.2, ss.229-235, 2025 (Scopus)

30. A Complex TRAPS Case in a SLE Patient on Immunosuppressive Therapy Post-Organ Transplant

Aktas B., Parlar K., UĞURLU S.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , cilt.28, sa.1, 2025 (SCI-Expanded, Scopus)

31. Targeting complement dysregulation: eculizumab in scleroderma renal crisis management-a case-based review

TOKER DİNÇER Z., DİNÇER M. T., Sen G., UĞURLU S., SEYAHİ N., SEYAHİ E.
RHEUMATOLOGY INTERNATIONAL , cilt.44, sa.12, ss.3135-3140, 2024 (SCI-Expanded, Scopus)

32. Characteristics of arthritis in patients with familial Mediterranean fever

Yenigun S., Ayla A. Y., Yuzbasioglu M. B., Baspinar S. N., Ergun S., Karabicek A., et al.
Internal Medicine Journal , cilt.54, sa.11, ss.1802-1808, 2024 (SCI-Expanded, Scopus)

33. REFRACTORY SWEET SYNDROME IN ASSOCIATION WITH FAMILIAL MEDITERRANEAN FEVER: A CASE REPORT

TOKER DİNÇER Z., Azman F. N., UĞURLU S.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , sa.10, 2024 (SCI-Expanded, Scopus)

34. EXPLORING S100A8/A9, NEOPTERIN, AND MMP3 IN FAMILIAL MEDITERRANEAN FEVER: INSIGHTS INTO PATHOGENESIS AND DIAGNOSTIC SIGNIFICANCE

Kilinc O. C., AKDENİZ Y. S., Taskin Z., Karabulut M., Kaya A., BOLAYIRLI İ. M., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , sa.10, 2024 (SCI-Expanded, Scopus)

35. ARTHRITIS AND ITS CHARACTERISTICS IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER

YENİGÜN S., Ayla A. Y., YÜZBAŞIOĞLU M. B., Baspinar S. N., Karabicek A., Demirkol F., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , sa.10, 2024 (SCI-Expanded, Scopus)

36. A rare case of uncharacterized autoinflammatory disease: Patient carrying variations in NLRP3 and TNFRSF1A genes

Kilinc O. C., Gayibova K., Onen M. O., ONAT U. İ., Bülbül A., TİMUÇİN A. C., et al.
American Journal of Medical Genetics, Part A , cilt.194, sa.10, 2024 (SCI-Expanded, Scopus)

37. Canakinumab Treatment in Patients with Familial Mediterranean Fever: A Tertiary Center Experience

Simsek O. B., Ayla A., UĞURLU S.
ARTHRITIS & RHEUMATOLOGY , ss.4136-4137, 2024 (SCI-Expanded, Scopus)

38. Path to Diagnosis in Familial Mediterranean Fever (FMF)

Karup S., Polat D., Dincsoy E., Azman F. N., Cokrak M. E., Berkiten E., et al.
ARTHRITIS & RHEUMATOLOGY , ss.586-587, 2024 (SCI-Expanded, Scopus)

39. Anakinra in idiopathic recurrent pericarditis: a comprehensive case series and literature review Anakinra bei idiopathischer rezidivierender Perikarditis: umfangreiche Fallserie und Literaturübersicht

Toker Dincer Z., Karup S., YILMAZ B. E., Corbali O., Azman F. N., MELİKOĞLU M., et al.
Zeitschrift fur Rheumatologie , cilt.83, sa.7, ss.587-596, 2024 (SCI-Expanded, Scopus)

40. Evaluation of Medication Adherence of FMF Patients Transitioned from a Pediatric Clinic to an Adult Clinic: A Cross-sectional Study

AVCI F. Z., Azman F. N., Unsal E. S., UĞURLU S.
ARTHRITIS & RHEUMATOLOGY , ss.4142-4143, 2024 (SCI-Expanded, Scopus)

41. Long-Term Echocardiographic Findings in Idiopathic Recurrent Pericarditis Patients Treated with Anakinra

TOKER DİNÇER Z., Raimoglu D., YILMAZ ALARÇİN E., DAĞ A., Karup S., MELİKOĞLU M., et al.
ARTHRITIS & RHEUMATOLOGY , ss.2279-2281, 2024 (SCI-Expanded, Scopus)

42. Novel use of interleukin-1 antagonists in male familial Mediterranean fever patients with infertility: Case series

Egeli B., Parlar K., Filiz B., Durucan I., UĞURLU S.
ARCHIVES OF RHEUMATOLOGY , sa.3, ss.474-475, 2024 (SCI-Expanded, Scopus, TRDizin)

43. The Journey of a Patient with Psoriatic Arthritis: The Path from Diagnosis to Treatment

Azman F. N., Tanin K., Sacin E., Azman E., Rizaoglu M., Uc C., et al.
ARTHRITIS & RHEUMATOLOGY , ss.2208-2210, 2024 (SCI-Expanded, Scopus)

44. Severity scores, damage indices, and the concept of the colchicine-resistant patient in familial Mediterranean fever

Er O., Akay H., Ozgozen M. E., Gulhan D., UĞURLU S.
MODERN RHEUMATOLOGY , sa.1, ss.7-16, 2024 (SCI-Expanded, Scopus)

45. Exploring S100A8/A9, neopterin, and MMP3 in familial Mediterranean fever

Kilinc O. C., AKDENİZ Y. S., Taskin Z., Karabulut M., Kaya A., BOLAYIRLI İ. M., et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY , sa.1, ss.93-100, 2024 (SCI-Expanded, Scopus)

46. Unprecedented coexistence of autoinflammatory myositis and chronic thrombosis with heterozygotic M694V mutation: An atypical presentation of familial Mediterranean fever

Bahar F., UĞURLU S.
MODERN RHEUMATOLOGY CASE REPORTS , cilt.8, ss.383-385, 2024 (ESCI, Scopus)

47. Factors triggering familial mediterranean fever attacks, do they really exist?

Parlar K., Ates M. B., Onal M. E., Bostancı E., Azman F. N., UĞURLU S.
Internal and Emergency Medicine , cilt.19, sa.4, ss.1007-1013, 2024 (SCI-Expanded, Scopus) Creative Commons License

48. Efficacy and safety of biologic drugs in Still's disease: a systematic review and network meta-analysis of randomized controlled trials

Kilic B., Ozturk A., Karup S., Hacioglu E., UĞURLU S.
RHEUMATOLOGY , sa.1, ss.22-31, 2024 (SCI-Expanded, Scopus)

49. Efficacy and safety of anti-interleukin-1 treatment in familial Mediterranean fever patients: a systematic review and meta-analysis

Kilic B., Guler Y., Azman F. N., Bostanci E., UĞURLU S.
RHEUMATOLOGY , cilt.63, ss.925-935, 2024 (SCI-Expanded, Scopus)

50. Case report: Other autoinflammatory mutations in a patient with atypical familial Mediterranean fever symptoms

Hacıoglu E., Er O., Karup S., UĞURLU S.
International Journal of Rheumatic Diseases , cilt.27, sa.4, 2024 (SCI-Expanded, Scopus)

51. Fertilization, reproductive system, and pregnancy in familial Mediterranean fever: Clinical state of art

Er O., UĞURLU S.
MODERN RHEUMATOLOGY , cilt.34, ss.265-271, 2024 (SCI-Expanded, Scopus)

52. Anxiety and depression among patients with familial Mediterranean fever Angst und Depression bei Patienten mit familiärem Mittelmeerfieber

Kilinc O. C., Kilinc A., Azman F. N., Ardac S., Egeli B., DEMİREL Ö. F., et al.
Zeitschrift fur Rheumatologie , cilt.83, sa.Suppl 1, ss.236-241, 2024 (SCI-Expanded, Scopus)

53. Comment on: Pregnancy outcomes in patients with familial Mediterranean fever: systematic review and meta-analysis

KILIÇ B., Parlar K., UĞURLU S.
Rheumatology (United Kingdom) , cilt.63, sa.2, 2024 (SCI-Expanded, Scopus)

54. The clinical role of anakinra in the armamentarium against familial Mediterranean fever

Parlar K., Ates M. B., Egeli B. H., UĞURLU S.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY , cilt.20, sa.5, ss.441-453, 2024 (SCI-Expanded, Scopus)

55. Infliximab as successful treatment option in a case of adenosine deaminase 2 deficiency

Ates M. B., Karup S., UĞURLU S.
REUMATISMO , cilt.75, sa.4, ss.225-228, 2023 (ESCI, Scopus) Sürdürülebilir Kalkınma

56. Comment on: Increased risk of osteoporosis and femoral neck fractures in patients with familial Mediterranean fever-a large retrospective cohort study

Parlar K., Kilic B., UĞURLU S.
RHEUMATOLOGY , 2023 (SCI-Expanded, Scopus)

57. A different presentation of tubulointerstitial nephritis and uveitis syndrome mimicking Sjögren's syndrome

Yilmaz R., MURT A., GÜRSES İ., UĞURLU S.
ARCHIVES OF RHEUMATOLOGY , cilt.38, sa.4, ss.659-661, 2023 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

58. Clinical features of dermatomyositis patients with anti-TIF1 antibodies: A case based comprehensive review

Kilinc O. C., UĞURLU S.
Autoimmunity Reviews , cilt.22, sa.12, 2023 (SCI-Expanded, Scopus)

59. Cancer incidence in Familial Mediterranean Fever: A retrospective analysis.

Baspinar S. N., KILIÇ B., Azman F. N., Guler Y., Gunay U. B., Tanin M. K., et al.
Seminars in arthritis and rheumatism , cilt.63, ss.152284, 2023 (SCI-Expanded, Scopus)

60. Paternal Effects of Anti-TNFs in Inflammatory Arthritis

TOKER DİNÇER Z., Ates B., DAĞ A., TÜRKOĞLU İ., Ayla A. Y., UĞURLU S.
ARTHRITIS & RHEUMATOLOGY , ss.2647-2648, 2023 (SCI-Expanded, Scopus)

61. De Novo Manifestations During Adalimumab Treatment in Behcet Syndrome

ESATOĞLU S. N., SÖNMEZ Ö., UÇAR D., Kaymaz E., ÖZGÜLER Y., UĞURLU S., et al.
ARTHRITIS & RHEUMATOLOGY , ss.3070-3072, 2023 (SCI-Expanded, Scopus)

62. Cancer Incidence in Familial Mediterranean Fever

Baspinar S. N., Kilic B., Azman F., YÜZBAŞIOĞLU M. B., Guler Y., Tanin M. K., et al.
ARTHRITIS & RHEUMATOLOGY , ss.263-265, 2023 (SCI-Expanded, Scopus)

63. Comparison of telerehabilitation methods for patients with systemic sclerosis in the COVID-19 Era: A randomized controlled study

ÇİVİ KARAASLAN T., TARAKCI E., Keles O., Aslan Keles Y., UĞURLU S.
Journal of Hand Therapy , cilt.36, sa.4, ss.751-769, 2023 (SCI-Expanded, Scopus)

64. Detection of a rare variant in PSTPIP1 through three generations in a family with an initial diagnosis of FMF/MKD-overlapping phenotype

Onen M. O., ONAT U. İ., Ugurlu S., TİMUÇİN A. C., ÖZ ARSLAN D., Everest E., et al.
RHEUMATOLOGY , cilt.62, sa.9, ss.3188-3196, 2023 (SCI-Expanded, Scopus)

65. Rituximab in the management of retroperitoneal fibrosis: A single tertiary rheumatology care center experience

Oztas M., Altun I., Ayla A. Y., Cerme E., Demirdag C., ASA S., et al.
International Journal of Rheumatic Diseases , cilt.26, sa.9, ss.1714-1721, 2023 (SCI-Expanded, Scopus)

66. A Different Presentation of Tubulointerstitial Nephritis and Uveitis (TINU) Syndrome mimicking Sjogren's Syndrome

Yilmaz R., Murt A., Gurses I., UĞURLU S.
SWISS MEDICAL WEEKLY , 2023 (SCI-Expanded, Scopus)

67. A review of rheumatoid meningitis with case studies.

Aktan Suzgun M., Erener N., Cavus G. H., Ozdede A., Guner S., UĞURLU S., et al.
Modern rheumatology case reports , cilt.7, sa.2, ss.340-346, 2023 (ESCI)

68. ANXIETY AND DEPRESSION IN PATIENTS WITH FMF

Egeli B., Kilinc O., Kilinc A., Azman F. N., Ardac S., UĞURLU S.
ANNALS OF THE RHEUMATIC DISEASES , ss.1985, 2023 (SCI-Expanded, Scopus)

69. CARDIOVASCULAR DISEASES IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER OVER 50 YEARS OF AGE

Karup S., Ayci B., Baspinar S. N., Azman F. N., UĞURLU S.
ANNALS OF THE RHEUMATIC DISEASES , ss.1161-1162, 2023 (SCI-Expanded, Scopus)

70. TOCILIZUMAB TREATMENT IN SEVERE AND REFRACTORY BEHCET'S SYNDROME: A CASE SERIES

Dincer Z. T., Yurttas B., Esatoglu S. N., Ucar D., Uygunoglu U., UĞURLU S., et al.
ANNALS OF THE RHEUMATIC DISEASES , ss.1571, 2023 (SCI-Expanded, Scopus)

71. PSYCHOMETRIC PROPERTIES OF SCREENING INSTRUMENTS FOR PSORIATIC ARTHRITIS

Ozdede A., Ayan G., Can G., Bektas M., Akdogan N., Solak E. O., et al.
ANNALS OF THE RHEUMATIC DISEASES , ss.1796-1797, 2023 (SCI-Expanded, Scopus)

72. The First Case Report of 47,XXY/46,XX/46,XY Mosaic Klinefelter Syndrome Patient With Mixed Connective Tissue Disorder

KALAYCI YİĞİN A., Alay M. T., UĞURLU S., SEVEN M.
American Journal of Men's Health , cilt.17, sa.3, 2023 (SSCI, Scopus)

73. Post-COVID-19 vaccination inflammatory syndrome: A case report.

Durucan I., Guner S., Kilickiran Avci B., Unverengil G., MELİKOĞLU M., UĞURLU S.
Modern rheumatology case reports , cilt.7, sa.1, ss.280-282, 2023 (ESCI) Creative Commons License

74. Screening of antigliadin and antitissue transglutaminase antibodies in patients with chronic plaque psoriasis: a case-control study

ENGİN B., Hüseynova Ç., Ak T., Ayla A. Y., Can G., UĞURLU S.
Turkish Journal of Medical Sciences , cilt.53, sa.2, ss.544-551, 2023 (SCI-Expanded, Scopus, TRDizin)

75. Frequency of AA amyloidosis has decreased in Behcet's syndrome: a retrospective study with long-term follow-up and a systematic review Amyloidosis in Behcet's syndrome

Karatemiz G., ESATOĞLU S. N., Gurcan M., ÖZGÜLER Y., YURDAKUL S., HAMURYUDAN V., et al.
RHEUMATOLOGY , cilt.62, sa.1, ss.9-18, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

76. Familial Mediterranean fever: clinical state of the art

Egeli B. H., UĞURLU S.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE , cilt.115, sa.11, ss.711-718, 2022 (SCI-Expanded, Scopus)

77. Canakinumab Treatment in Familial Mediterranean Fever Patients with Colchicine Resistance: A Single-center Study

Durucan I., Ayla A. Y., Besiroglu H. I., Alkan A., SELVİ O., Ozdogan H., et al.
ARTHRITIS & RHEUMATOLOGY , ss.3623-3625, 2022 (SCI-Expanded, Scopus)

78. Outcome of Vascular Involvement of Behcet Syndrome Treated with Infliximab: A Retrospective Cohort Study

HATEMİ G., TÜKEK N. B., ESATOĞLU S. N., ÖZGÜLER Y., Taflan S. S., MELİKOĞLU M., et al.
ARTHRITIS & RHEUMATOLOGY , ss.3098-3099, 2022 (SCI-Expanded, Scopus)

79. Characteristics of Arthritis in Familial Mediterranean Fever Patients

Ayla A. Y., YENİGÜN S., Baspinar S. N., YÜZBAŞIOĞLU M. B., Alkan A., Durucan I., et al.
ARTHRITIS & RHEUMATOLOGY , ss.3618-3619, 2022 (SCI-Expanded, Scopus)

80. Appendicitis Still a Challenge for FMF Patients?

Baspinar S. N., Alkan A., YÜZBAŞIOĞLU M. B., Yenigun S., Ayla A. Y., Durucan I., et al.
ARTHRITIS & RHEUMATOLOGY , ss.3633-3634, 2022 (SCI-Expanded, Scopus)

81. Assessment of the Transition of Care from Pediatric to Adult Rheumatology in a Tertiary Center

UĞURLU S., Ayla A. Y., Besiroglu H. I., Azman F. N., Egeli B., Eren H., et al.
ARTHRITIS & RHEUMATOLOGY , ss.2565-2567, 2022 (SCI-Expanded, Scopus)

82. Late-onset familial mediterranean fever: single-center experience and literature review

Aydin O., Egeli B. H., Ozdogan H., UĞURLU S.
Internal and Emergency Medicine , cilt.17, sa.5, ss.1301-1306, 2022 (SCI-Expanded, Scopus) Creative Commons License

83. An unusual sacral joint localization of granulomatosis with polyangiitis detected by [18F]FDG PET/CT Una localización inusual de granulomatosis con poliangitis en la articulación sacra detectada por la PET/TC con [18F]FDG

Akgun E., Halac M., UĞURLU S., SÖNMEZOĞLU K.
Revista Espanola de Medicina Nuclear e Imagen Molecular , cilt.41, sa.4, ss.261-263, 2022 (SCI-Expanded, Scopus)

84. Frequency and severity of COVID-19 in patients with various rheumatic diseases treated regularly with colchicine or hydroxychloroquine

ÖZTAŞ M., BEKTAŞ M., KARACAN İ., Aliyeva N., DAĞ A., Aghamuradov S., et al.
JOURNAL OF MEDICAL VIROLOGY , cilt.94, sa.7, ss.3431-3437, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

85. An unusual sacral joint localization of granulomatosis with polyangiitis detected by [F-18]FDG PET/CT

Akgun E., Halac M., UĞURLU S., SÖNMEZOĞLU K.
REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR , cilt.41, sa.4, ss.261-263, 2022 (SCI-Expanded, Scopus)

86. Antibody responses to inactivated and mRNA SARS-CoV-2 vaccines in familial Mediterranean fever patients treated with interleukin-1 inhibitors

UĞURLU S., Akcin R., Ayla A. Y., KOCAZEYBEK B. S., ÖZTAŞ M., CAN G., et al.
RHEUMATOLOGY , cilt.61, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

87. COMPARISON OF TELEREHABILITATION METHODS FOR SYSTEMIC SCLEROSIS PATIENTS IN THE COVID-19 ERA: A RANDOMIZED CONTROLLED STUDY

Karaaslan T. C., TARAKCI E., Keles O., Keles Y. A., UĞURLU S.
ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.1850, 2022 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

88. AWARENESS OF BIOLOGICAL AGENTS RELATED SIDE EFFECTS AMONG INTERNAL MEDICINE RESIDENTS IN A UNIVERSITY HOSPITAL

Oztas M., UĞURLU S.
ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.1854, 2022 (SCI-Expanded, Scopus) Creative Commons License

89. A NEW SCREENING TOOL FOR PSORIATIC ARTHRITIS IN PSORIASIS PATIENTS: TURPAS

AYAN G., Hatemi G., Can G., Bektas M., Ozdede A., Akdogan N., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.1597-1598, 2022 (SCI-Expanded, Scopus) Creative Commons License

90. Safety of SARS-CoV-2 vaccination in patients with Behcet's syndrome and familial Mediterranean fever: a cross-sectional comparative study on the effects of M-RNA based and inactivated vaccine

Ozdede A., GÜNER S., Ozcifci G., YURTTAŞ B., TOKER DİNCER Z., Atli Z., et al.
RHEUMATOLOGY INTERNATIONAL , cilt.42, ss.973-987, 2022 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

91. OUTCOME OF VASCULAR INVOLVEMENT OF BEHCET'S SYNDROME TREATED WITH INFLIXIMAB: A RETROSPECTIVE COHORT STUDY

Hatemi G., Tukek B., Esatoglu S. N., Ozguler Y., Taflan S. S., Melikoglu M., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.696-697, 2022 (SCI-Expanded, Scopus) Creative Commons License

92. DOES TESTING FOR SAA IS MORE BENEFICIAL THAN CRP FOR THE FOLLOW-UP OF PATIENTS WITH FMF?

Oztas M., Selvi O., Ergezen B., Ozdogan H., UĞURLU S.
ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.1840-1841, 2022 (SCI-Expanded, Scopus) Creative Commons License

93. A SYSTEMATIC REVIEW OF AA AMYLOIDOSIS AMONG PATIENTS WITH BEHCET'S SYNDROME

Karatemiz G., Esatoglu S. N., Gurcan M., Ozguler Y., Yurdakul S., Hamuryudan V., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.1758-1759, 2022 (SCI-Expanded, Scopus) Creative Commons License

94. SAFETY OF THE PFIZER/BIONTECH AND SINOVAC/CORONAVAC VACCINES AMONG PATIENTS WITH BEHCET'S SYNDROME AND FAMILIAL MEDITERRANEAN FEVER

Ozdede A., Guner S., Ozcifci G., Yurttas B., Dincer Z. T., Atli Z., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.962-963, 2022 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

95. FREQUENCY AND SEVERITY OF COVID-19 IN PATIENTS WITH VARIOUS RHEUMATIC DISEASES TREATED REGULARLY WITH COLCHICINE OR HYDROXYCHLOROQUINE

Oztas M., Bektas M., Karacan I., Aliyeva N., Dag A., Aghamuradov S., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.1660-1661, 2022 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

96. THE MYSTERY OF FAMILIAL MEDITERRANEAN FEVER: IS THERE ANY FACTOR TRIGGERING THE ATTACKS?

Baspinar S. N., Durucan I., Yuzbasioglu M. B., Yenigun S., Ayla A. Y., Alkan A., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.1767-1768, 2022 (SCI-Expanded, Scopus) Creative Commons License

97. The incidence, clinical characteristics, and outcome of COVID-19 in a prospectively followed cohort of patients with Behcet's syndrome

Ozcifci G., Aydin T., Atli Z., BALKAN İ. İ., TABAK Ö. F., ÖZTAŞ M., et al.
RHEUMATOLOGY INTERNATIONAL , cilt.42, sa.1, ss.101-113, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

98. Haemophagocytic lymphohistiocytosis in a patient with familial Mediterranean fever and miliary tuberculosis: a case report

ÇERME E., ÖZTAŞ M., BALKAN İ. İ., Cetin E. A., UĞURLU S.
MODERN RHEUMATOLOGY CASE REPORTS , cilt.6, sa.1, ss.140-144, 2022 (ESCI, Scopus) Sürdürülebilir Kalkınma

99. Rituximab as a glucocorticoid-sparing agent in idiopathic inflammatory myopathies: a retrospective single-center cohort study

Egeli B. H., Ergun S., Cetin A., Gursoy Y. K., UĞURLU S.
CLINICAL RHEUMATOLOGY , cilt.41, sa.1, ss.123-127, 2022 (SCI-Expanded, Scopus)

100. Presentation characteristics and clinical outcome of patients with giant cell arteritis followed by a single center

Oztas M., Ozgul H., Seyahi E., Ugurlu S.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.52, sa.4, ss.917-925, 2022 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

101. Idiopathic granulomatous mastitis associated with erythema nodosum may indicate a worse prognosis

VELİDEDEOĞLU M., PAPİLA KUNDAKTEPE B., METE B., UĞURLU S.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , cilt.24, sa.11, ss.1370-1377, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

102. ADULT-ONSET STILL'S DISEASE: A SINGLE-CENTER EXPERIENCE

Egeli B., UĞURLU S.
ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.966, 2021 (SCI-Expanded, Scopus)

103. BIOLOGIC TREATMENT OF ADULT-ONSET STILL'S DISEASE: A SINGLE CENTER EXPERIENCE

Yurttas B., Egeli B., Ozkose G. G., UĞURLU S.
ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.974, 2021 (SCI-Expanded, Scopus)

104. INFLIXIMAB FOR VASCULAR INVOLVEMENT IN BEHCET SYNDROME

Hatemi G., Tukek B., Esatoglu S. N., Ozguler Y., Melikoglu M., Caliskan E. B., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.663, 2021 (SCI-Expanded, Scopus)

105. INSTRUMENTS FOR SCREENING PSORIATIC ARTHRITIS AMONG PATIENTS WITH PSORIASIS: A SYSTEMATIC LITERATURE REVIEW

Can G., Ayan G., Ozdede A., BEKTAŞ M., Akdogan N., Yalici-Armagan B., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.1327, 2021 (SCI-Expanded, Scopus)

106. CAUSES OF HOSPITALIZATION IN BEHCET SYNDROME

Ozguler Y., Hatemi G., Pala A. S., Esatoglu S. N., UĞURLU S., SEYAHİ E., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.958, 2021 (SCI-Expanded, Scopus)

107. Willingness to get the COVID-19 vaccine among patients with rheumatic diseases, healthcare workers and general population in Turkey: a web-based survey

YURTTAŞ B., POYRAZ B. Ç., SÜT N., Ozdede A., ÖZTAŞ M., UĞURLU S., et al.
RHEUMATOLOGY INTERNATIONAL , cilt.41, sa.6, ss.1105-1114, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

108. Anakinra treatment in patients with familial Mediterranean fever: a single-centre experience

UĞURLU S., Ergezen B., Egeli B. H., SELVİ O., Ozdogan H.
RHEUMATOLOGY , cilt.60, sa.5, ss.2327-2332, 2021 (SCI-Expanded, Scopus)

109. A rare case of an NLRP12-associated autoinflammatory disease

Ayla A. Y., Eren H., Zare J., Calhan S. S., KARACAN İ., Seven M., et al.
EUROPEAN JOURNAL OF MEDICAL GENETICS , cilt.64, sa.4, 2021 (SCI-Expanded, Scopus)

110. COVID-19 Among Patients With Inflammatory Rheumatic Diseases

Esatoglu S. N., Tascilar K., Babaoglu H., Bes C., YURTTAŞ B., AKAR S., et al.
FRONTIERS IN IMMUNOLOGY , cilt.12, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

111. Soluble TREM-1 Levels in Familial Mediterranean Fever Related AA-Amyloidosis

Ugurlu S., Egeli B. H., Bolayirli I. M., Ozdogan H.
IMMUNOLOGICAL INVESTIGATIONS , cilt.50, sa.2-3, ss.273-281, 2021 (SCI-Expanded, Scopus)

112. Safety and efficacy of anti-interleukin-1 treatment in 40 patients, followed in a single centre, with AA amyloidosis secondary to familial Mediterranean fever

UĞURLU S., Ergezen B., Egeli B. H., Selvi O., Ozdogan H.
Rheumatology (Oxford, England) , cilt.59, sa.12, ss.3892-3899, 2020 (SCI-Expanded, Scopus)

113. The Prevalence of Familial Mediterranean Fever and Behcet's Disease: A Cross-Sectional Study

ALPARSLAN Ö., Egeli B. H., DEMİREL Y., Ugurlu S.
ARCHIVES OF RHEUMATOLOGY , cilt.35, sa.4, ss.609-613, 2020 (SCI-Expanded, Scopus, TRDizin)

114. Comment on: Serum Strem-1 in adult-onset Still's disease: a novel biomarker of disease activity and a potential predictor of the chronic course

Ugurlu S., Egeli B. H.
RHEUMATOLOGY , cilt.59, sa.11, 2020 (SCI-Expanded, Scopus)

115. Alendronate induced subacute cutaneous lupus erythematosus successfully treated with intravenous immunoglobulin

Uzuncakmak T. K., Bayazit S., Askin Ö., Engin B., Ugurlu S., Sar M., et al.
Dermatologic Therapy , cilt.33, sa.6, 2020 (SCI-Expanded, Scopus)

116. The efficacy of anti- IL-1 treatment in three patients with coexisting familial Mediterranean fever and multiple sclerosis

Ozdogan H., Ugurlu S., Uygunoglu U., Tutuncu M., Gul A., Akman G., et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS , cilt.45, 2020 (SCI-Expanded, Scopus)

117. Long term follow-up of Behçet's syndrome patients treated with cyclophosphamide.

Gurcan M., Esatoglu S. N., Hamuryudan V., Saygin D., Ugurlu S., Seyahi E., et al.
Rheumatology (Oxford, England) , cilt.59, sa.9, ss.2264-2271, 2020 (SCI-Expanded, Scopus)

118. In Familial Mediterranean Fever, soluble TREM-1 plasma level is higher in case of amyloidosis

UĞURLU S., Egeli B. H.
INNATE IMMUNITY , cilt.26, sa.3, ss.231, 2020 (SCI-Expanded, Scopus)

119. Clinical course of acute deep vein thrombosis of the legs in Behçet's syndrome

Ozguler Y., Hatemi G., Cetinkaya F., Tascilar K., Hamuryudan V., Ugurlu S., et al.
Rheumatology (United Kingdom) , cilt.59, sa.4, ss.799-806, 2020 (SCI-Expanded, Scopus)

120. Comment on: Clinical course of acute deep vein thrombosis of the legs in Behçet's syndrome: Reply

Ozguler Y., Hatemi G., Cetinkaya F., Tascilar K., Hamuryudan V., Ugurlu S., et al.
Rheumatology (United Kingdom) , cilt.59, sa.4, ss.914-915, 2020 (SCI-Expanded, Scopus)

121. Takayasu's arteritis: associated inflammatory diseases

Esatoglu S. N., Ok A. M., Ucar D., Celik A. F., Ugurlu S., Hamuryudan V., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.38, sa.2, 2020 (SCI-Expanded, Scopus)

122. Familial Mediterranean fever: misdiagnosis and diagnostic delay in Turkey

Erdogan M., Ugurlu S., Ozdogan H., Seyahi E.
Clinical and experimental rheumatology , cilt.37, sa.6, ss.119-124, 2019 (SCI-Expanded, Scopus)

123. Diagnostic utility of a targeted next-generation sequencing gene panel in the clinical suspicion of systemic autoinflammatory diseases: a multi-center study

Karacan İ., Balamir A., Ugurlu S., Aydin A. K., Everest E., Zor S., et al.
RHEUMATOLOGY INTERNATIONAL , sa.5, ss.911-919, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

124. Polyarteritis nodosa: lessons from 25 years of experience

SÖNMEZ H., ARMAĞAN B., Ayan G., Barut K., Batu E. D., Erden A., et al.
Clinical and experimental rheumatology , cilt.37, sa.2, ss.52-56, 2019 (SCI-Expanded, Scopus)

125. Familial Mediterranean Fever

OZDOGAN H., Ugurlu S.
PRESSE MEDICALE , cilt.48, sa.1, 2019 (SCI-Expanded, Scopus)

126. Does Testing for SAA Is More Beneficial Than CRP for the Follow-up of Patients with Familial Mediterranean Fever ?

Ugurlu S., Selvi O., Ergezen B., Ozdogan H.
ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded, Scopus)

127. Anakinra Treatment in Refractory Cases of Adult-Onset Still Disease: Case Series

UĞURLU S., Yurttas B., Guzelant G., Ergezen B., Ozdogan H.
ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded, Scopus)

128. Retrospective Analysis of Initial Presentation Findings of Behcet's Syndrome throughout 4 Decades

Dincses E., Ozguler Y., Ucar D., Ozyazgan Y., Ugurlu S., Hatemi G., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded, Scopus)

129. Canakinumab Treatment in Adult-Onset Still's Disease: Case Series

UĞURLU S., Guzelant G., Yurttas B., Ergezen B., DALKILIÇ H. E., KAŞİFOĞLU T., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded, Scopus)

130. Anti-Il-1 Therapies in Patients with Familial Mediterranean Fever Related AA-Amyloidosis

Ergezen B., Ugurlu S., Selvi O., Egeli B. H., Ozdogan H.
ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded, Scopus)

131. LACC1 Gene Defects in Familial Form of Juvenile Arthritis

Karacan İ., Ugurlu S., Sahin S., Everest E., Kasapcopur O., Tolun A., et al.
JOURNAL OF RHEUMATOLOGY , sa.5, ss.726-728, 2018 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

132. Rituximab for anti-neutrophil cytoplasmic antibodies-associated vasculitis: experience of a single center and systematic review of non-randomized studies

Ayan G., Esatoglu S. N., Hatemi G., Ugurlu S., Seyahi E., Melikoglu M., et al.
RHEUMATOLOGY INTERNATIONAL , cilt.38, sa.4, ss.607-622, 2018 (SCI-Expanded, Scopus)

133. An update on pulmonary artery involvement in Behcet's syndrome: more pulmonary artery thrombotic disease and a better outcome

Ozguler Y., Dincses E., Bakan S., Hatemi G., Melikoglu M., Ugurlu S., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.36, sa.6, 2018 (SCI-Expanded, Scopus)

134. Retrospective analysis of initial presentation findings of Behcet's syndrome throughout 4 decades

Dincses E., Ozguler Y., Ucar D., Ozyazgan Y., Ugurlu S., Hatemi G., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.36, sa.6, 2018 (SCI-Expanded, Scopus)

135. Clinical, imaging and genotypical features of three deceased and five surviving cases with ADA2 deficiency

Sahin S., Adrovic A., Barut K., Ugurlu S., Turanli E. T., Ozdogan H., et al.
RHEUMATOLOGY INTERNATIONAL , cilt.38, sa.1, ss.129-136, 2018 (SCI-Expanded, Scopus)

136. DERMATOMYOSITIS ASSOCIATED WITH PAPILLARY THYROID CANCER: A CASE REPORT AND REVIEW OF LITERATURE

Ugurlu S., Yilmaz U., Ozdogan H.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.36, sa.1, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

137. Factors associated with damage progression in Behcet's syndrome uveitis

Ozyazgan Y., Ucar D., ERDOĞAN M., Ozguler Y., Gulen G., Sebahattin S., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.36, sa.6, 2018 (SCI-Expanded, Scopus)

138. International multi-centre study of pregnancy outcomes with interleukin-1 inhibitors

Youngstein T., Hoffmann P., Gül A., Lane T., Williams R., Rowczenio D. M., et al.
RHEUMATOLOGY , cilt.56, ss.2102-2108, 2017 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

139. C-Reactive Protein and Serum Amyloid a in Sepsis, Acute Appendicitis and Familial Mediterranean Fever

Selvi O., Ugurlu S., Bolayirli M., Barut K., Sahin S., Adrovic A., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.69, 2017 (SCI-Expanded, Scopus)

140. Long-term follow-up of secondary amyloidosis patients treated with tumor necrosis factor inhibitor therapy: A STROBE-compliant observational study.

Esatoglu S. N., Hatemi G., Ugurlu S., Gokturk A., Tascilar K., Ozdogan H.
Medicine , cilt.96, sa.34, 2017 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

141. Myelopathy in Behçet's disease: The Bagel Sign

Uygunoglu U., Zeydan B., Ozguler Y., Ugurlu S., Seyahi E., Kocer N., et al.
Annals of Neurology , cilt.82, sa.2, ss.288-298, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

142. Atorvastatin-induced dermatomyositis

Oztas M., Ugurlu S., Aydin Ö.
RHEUMATOLOGY INTERNATIONAL , cilt.37, sa.7, ss.1217-1219, 2017 (SCI-Expanded, Scopus)

143. Tocilizumab in the treatment of twelve cases with aa amyloidosis secondary to familial mediterranean fever

Ugurlu S., Hacioglu A., Adibnia Y., Hamuryudan V., Ozdogan H.
ORPHANET JOURNAL OF RARE DISEASES , cilt.12, 2017 (SCI-Expanded, Scopus) Creative Commons License

144. Glucagon-like peptide-1 levels and dipeptidyl peptidase-4 activity in type 2 diabetes

SENYIGIT A., Tabak O., ORBANOGLU T., Karadag A., Ugurlu S., Uzun H., et al.
Clinical and Investigative Medicine , cilt.40, sa.5, 2017 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

145. Inadequate reporting of enrolled patient and study site characteristics, and inter-study site differences in randomized controlled trials: A systematic review in six leading medicine journals

Yurdakul S., Ayan G., Ozguler Y., Hatemi G., Ugurlu S., Seyahi E., et al.
European Journal of Internal Medicine , cilt.37, 2017 (SCI-Expanded, Scopus)

146. Other autoinflammatory disease genes in an FMF-prevalent population: a homozygous MVK mutation and a heterozygous TNFRSF1A mutation in two different Turkish families with clinical FMF

Karacan İ., Ugurlu S., Tolun A., Turanli E. T., Ozdogan H.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , sa.6, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

147. Canakinumab for the treatment of familial Mediterranean fever

Ozdogan H., Ugurlu S.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY , cilt.13, sa.5, ss.393-404, 2017 (SCI-Expanded, Scopus)

148. Re-initiation of biologics after the development of tuberculosis under anti-TNF therapy

Ozguler Y., Hatemi G., Ugurlu S., Seyahi E., Melikoglu M., Borekci Ş., et al.
RHEUMATOLOGY INTERNATIONAL , cilt.36, sa.12, ss.1719-1725, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

149. Bronchial artery enlargement may be the cause of recurrent haemoptysis in Behcet's syndrome patients with pulmonary artery involvement during follow-up

Esatoglu S. N., Seyahi E., Ugurlu S., Gulsen F., Akman C., Cantasdemir M., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.34, sa.6, 2016 (SCI-Expanded, Scopus)

150. Effect of colchicine on serum lipid levels

Ugurlu S., Seyahi E., Hanci I., PEHLEVAN S., Ozdogan H., Yazici H.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.34, sa.6, 2016 (SCI-Expanded, Scopus)

151. OSTEOPONTIN LEVELS AND OTHER IN OCULAR BEHCET'S DISEASE: A CONTROLLED STUDY

Tuzcu A., Ugurlu S., Ozyazgan Y., Andican G., Yazici H.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , sa.6, 2016 (SCI-Expanded, Scopus)

152. BEHCET'S SYNDROME ASSOCIATED WITH TAKAYASU'S ARTERITIS: A CASE SERIES OF 10 PATIENTS

Esatoglu S. N., Seyahi E., Ugurlu S., Hatemi G., Melikoglu M., Hamuryudan V., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.34, sa.6, 2016 (SCI-Expanded, Scopus)

153. ANTI-Interleukin 1 Therapy in FMF Amyloidosis: A Single Center Experience

Ugurlu S., Ergezen B., Ozdogan H.
ARTHRITIS & RHEUMATOLOGY , cilt.68, 2016 (SCI-Expanded, Scopus)

154. Associated Inflammatory Diseases in Takayasu's Arteritis: The Many Faces of a Disease

Esatoglu S. N., Celik A. M., UÇAR D., Celik A. F., UĞURLU S., HATEMİ G., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.68, 2016 (SCI-Expanded, Scopus)

155. A NOVEL Missense Mvk mutation in a Family with Familial Mediterranean Fever-like Disease

Karacan I., Ugurlu S., TOLUN A., Tahir Turanlı E., Ozdogan H.
ARTHRITIS & RHEUMATOLOGY , cilt.68, 2016 (SCI-Expanded, Scopus)

156. Infliximab is a plausible alternative for neurologic complications of Behcet disease

Zeydan B., Uygunoglu U., Saip S., Demirci O. N., Seyahi E., Ugurlu S., et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION , cilt.3, sa.5, 2016 (SCI-Expanded, Scopus) Creative Commons License

157. Rituximab in Systemic Sclerosis-Interstitial Lung Disease, a Case Series of 18 Patients

Guzelant G., Melikoglu M., Musellim B., Yilmaz D. D., Fresko I., Seyahi E., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.68, 2016 (SCI-Expanded, Scopus)

158. Granulomatosis Polyangiitis Presenting With Bilateral Serous Otitis Media, Unilateral Facial Paralysis And Parotitis, Early Diagnosis And Follow Up

BATIOĞLU KARAALTIN A., Gluyev J., ALASKAROV E., UĞURLU S., KARAMAN E.
ENTcase , 2016 (TRDizin)

159. Pulmonary artery involvement in Behçet's syndrome: Effects of anti-Tnf treatment

Hamuryudan V., Seyahi E., Ugurlu S., Melikoglu M., Hatemi G., Ozguler Y., et al.
Seminars in Arthritis and Rheumatism , cilt.45, sa.3, ss.369-373, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

160. Fatigue is correlated with disease activity but not with the type of organ involvement in Behcet's syndrome: a comparative clinical survey

Buyuktas D., Hatemi G., Yuksel-Findikoglu S., Ugurlu S., Yazici H., Yurdakul S.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.33, sa.6, 2015 (SCI-Expanded, Scopus)

161. Work Disability over Time in Behcet's Syndrome

Hatemi G., Tascilar K., Ozguler Y., Ugurlu S., Hamuryudan V.
ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded, Scopus)

162. Tocilizumab Is Effective in the Treatment of AA Amyloidosis Secondary to Familial Mediterranean Fever

Ozdogan H., Ugurlu S., Hacioglu A., Adibnia Y., Hamuryudan V.
ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded, Scopus)

163. Juvenile Spondyloarthropathies: a Single Center Experience

Barut K., Sezen M., Sahin S., Adrovic A., Ugurlu S., Ozdogan H., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded, Scopus)

164. Quality of Life Changes with Canakinumab Therapy in Adults with Colchicine Resistant FMF

Gül A., Ozdogan H., Kasapcopur O., Erer B., Ugurlu S., SEVGI S., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded, Scopus)

165. Bronchial Artery Enlargement May Cause Recurring Hemoptysis in Behcet's Syndrome Patients with Pulmonary Artery Involvement Despite Response to Treatment

Hamuryudan V., Seyahi E., Ugurlu S., Gulsen F., Akman C., Cantasdemir M., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded, Scopus)

166. Methylation Analysis of HLA-B Locus in Familial Behcet Syndrome

Turanli E. T., Koprulu P., Ugurlu S., Yazici H., Seyahi E.
ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded, Scopus)

167. Can We Differentiate Takayasu's Arteritis from Atherosclerosis Using Carotid Artery Doppler Usg?

UĞURLU S., KESKİN F. E., CETINKAYA F., MELİKOĞLU M., HAMURYUDAN V., FRESKO İ., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded, Scopus)

168. Canakinumab Therapy in Patients with Familial Mediterranean Fever

UĞURLU S., Seyahi E., Hatemi G., Hacioglu A., Ozcan H., Akkoc F. N., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded, Scopus)

169. How Safe IT Is to TREAT Pregnant FMF Patients with Anakinra ?

Ozdogan H., Ugurlu S., Ergezen B.
ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded, Scopus)

170. Takayasu's Arteritis Associated with Behcet's Syndrome: A Case Series of 8 Patients

Esatoglu S. N., Seyahi E., Ugurlu S., Hatemi G., Melikoglu M., Hamuryudan V., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded, Scopus)

171. Pathological and immunological features of autoinflammatory syndrome associated with lymphedema (AISLE)

Gul A., Ozdogan H., UĞURLU S., KASAPÇOPUR Ö., Buyukbabani N., Emekli U., et al.
Pediatric Rheumatology , cilt.13, sa.1, 2015 (SCI-Expanded, Scopus)

172. Efficacy and safety of canakinumab in adolescents and adults with colchicine-resistant familial Mediterranean fever

Gül A., Ozdogan H., Erer B., Ugurlu S., Kasapcopur O., Davis N., et al.
ARTHRITIS RESEARCH & THERAPY , cilt.17, 2015 (SCI-Expanded, Scopus) Creative Commons License

173. Venous claudication in Behçet's disease

Ugurlu S., Seyahi E., Oktay V., Kantarci F., Tuzun H., Yigit Z., et al.
Journal of Vascular Surgery , cilt.62, sa.3, ss.698, 2015 (SCI-Expanded, Scopus)

174. Restarting biologic agents in rheumatology patients who developed tuberculosis under TNF alpha-inhibitor treatment

Ozguler Y., Hatemi G., Ugurlu S., Seyahi E., Melikoglu M., Borekci S., et al.
EUROPEAN RESPIRATORY JOURNAL , cilt.46, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

175. HOW CORRECT ARE THE ASSUMPTIONS MADE DURING THE DEVELOPMENT OF TUBERCULOSIS SCREENING ALGORYTHMS BEFORE TNF-ALPHA ANTAGONISTS?

Hacioglu A., Ozguler Y., Borekci S., Hamuryudan V., Kecebas H., Tascilar E., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.74, ss.702, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

176. BRONCHIAL ARTERY ENLARGEMENT MAY BE THE CAUSE OF RECURRING HEMOPTYSIS IN BEHCET'S SYNDROME PATIENTS WITH PULMONARY ARTERY INVOLVEMENT DESPITE TREATMENT RESPONSE

Hamuryudan V., Seyahi E., Ugurlu S., Gulsen F., Akman C., Cantasdemir M., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.74, ss.304, 2015 (SCI-Expanded, Scopus)

177. WORK DISABILITY OVER TIME IN BEHCET'S SYNDROME PATIENTS

Hatemi G., Tascilar K., Ozguler Y., Ugurlu S., Hamuryudan V.
ANNALS OF THE RHEUMATIC DISEASES , cilt.74, ss.298-299, 2015 (SCI-Expanded, Scopus)

178. PREDICTORS OF QUALITY OF LIFE IN BEHCET'S SYNDROME

Bozcan S., Ozguler Y., Saygin C., Uzunaslan D., Tascilar K., Ugurlu S., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.74, ss.526, 2015 (SCI-Expanded, Scopus)

179. MALIGNANCIES IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TNF-ALPHA ANTAGONISTS

Ozguler Y., Esatoglu S. N., Keskin D., Hatemi G., Hamuryudan V., Pala A. S., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.74, ss.1040, 2015 (SCI-Expanded, Scopus)

180. ANTI-INTERLEUKIN-1 THERAPIES AND PREGNANCY OUTCOME: AN INTERNATIONAL COHORT

Youngstein T., Lane T., Rowczenio D., Ozdogan H., Ugurlu S., Hoffmann P., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.74, ss.860, 2015 (SCI-Expanded, Scopus)

181. RESTARTING BIOLOGICS IN PATIENTS WHO DEVELOPED TUBERCULOSIS DURING ANTI TNF-ALPHA TREATMENT

Ozguler Y., Hatemi G., Ugurlu S., Seyahi E., Melikoglu M., Borekci S., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.74, ss.472, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

182. THE PREGNANCY OUTCOMES IN FMF PATIENTS WHO ARE EXPOSED TO IL-1 BLOCKADE WITH ANAKINRA

Ozdogan H., Ugurlu S., Ergezen B.
ANNALS OF THE RHEUMATIC DISEASES , cilt.74, ss.400-401, 2015 (SCI-Expanded, Scopus)

183. JUVENILE SPONDYLOARTHROPATHIES: A SINGLE CENTER EXPERIENCE

Barut K., Sezen M., Sahin S., Adrovic A., Ugurlu S., Ozdogan H., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.74, ss.390, 2015 (SCI-Expanded, Scopus)

184. An outcome survey of 43 patients with Budd-Chiari syndrome due to Behcet's syndrome followed up at a single, dedicated center

Seyahi E., Caglar E., Ugurlu S., Kantarci F., Hamuryudan V., Sonsuz A., et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM , cilt.44, sa.5, ss.602-609, 2015 (SCI-Expanded, Scopus)

185. Parvovirus B19 infection as a cause of acute myositis in an adult

ÇAKIRCA M., KARATOPRAK C., Ugurlu S., ZORLU M., KISKAÇ M., ÇETİN G.
REVISTA BRASILEIRA DE REUMATOLOGIA , cilt.55, sa.2, ss.185-188, 2015 (SCI-Expanded, Scopus)

186. The Emerging Treatments in Familial Mediterranean Fever

Ozdogan H., Ugurlu S.
FAMILIAL MEDITERRANEAN FEVER , cilt.3, ss.137-157, 2015 (SCI-Expanded)

187. Fatigue is correlated with disease activity but not with the type of organ involvement in Behçet's syndrome: A comparative clinical survey

Buyuktas D., HATEMİ G., Yuksel-Findikoglu S., UĞURLU S., Yazici H., Yurdakul S.
Clinical and Experimental Rheumatology , cilt.33, ss.107-112, 2015 (SCI-Expanded, Scopus)

188. Interferon Alfa-Associated Depression in Patients with Behcet's Syndrome.

Keskin Y., Seyahi E., Poyraz C., Ugurlu S., Ozyazgan Y., Yazici H.
ARTHRITIS & RHEUMATOLOGY , cilt.66, 2014 (SCI-Expanded, Scopus)

189. Budd-Chiari Syndrome Due to Behcet's Syndrome: Some Patients Present without Liver Related Symptoms and Have a Better Outcome.

Seyahi E., Caglar E., Ugurlu S., Kantarci F., Hamuryudan V., Sonsuz A., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.66, 2014 (SCI-Expanded, Scopus)

190. The Clinical Course of Acute Deep Vein Thrombosis of the Legs in Behcet's Syndrome.

Melikoglu M., Ozguler Y., Ugurlu S., Cetinkaya F., Tascilar K., Seyahi E., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.66, 2014 (SCI-Expanded, Scopus)

191. Tocilizumab (TCZ) in the Treatment of AA Amyloidosis in Patients with Familial Mediterranean Fever.

Ozdogan H., UĞURLU S., Hacioglu A., Adibnia Y., HAMURYUDAN V.
ARTHRITIS & RHEUMATOLOGY , cilt.66, 2014 (SCI-Expanded, Scopus)

192. Canakinumab Therapy in Patients with Familial Mediterranean Fever.

UĞURLU S., Seyahi E., Hatemi G., Hacioglu A., Akkoc F. N., Ozdogan H.
ARTHRITIS & RHEUMATOLOGY , cilt.66, 2014 (SCI-Expanded, Scopus)

193. 18F-FDG PET/CT in Vascular Disease Due to Behcet's Syndrome.

Seyahi E., Hallac M., Vatankulu B., Ugurlu S., Melikoglu M., Yurdakul S., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.66, 2014 (SCI-Expanded, Scopus)

194. Anti-TNF Treatment for Refractory Vascular Involvement of Behcet's Syndrome.

Hamuryudan V., Seyahi E., Melikoglu M., Ugurlu S., Hatemi G., Yurdakul S., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.66, 2014 (SCI-Expanded, Scopus)

195. How Correct Are the Assumptions Made for Tuberculosis Screening Algorythms before TNF-Alpha Antagonists?

Hacioglu A., Ozguler Y., Borekci S., Hamuryudan V., Kecebas H. D., Tascilar E. K., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.66, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

196. Vascular involvement in behceţ's syndrome: Aretrospective analysis of associations and the time course

Tascilar K., Melikoglu M., Ugurlu S., Sut N., Caglar E., Yazici H.
Rheumatology (United Kingdom) , cilt.53, sa.11, ss.2018-2021, 2014 (SCI-Expanded, Scopus) Creative Commons License

197. Metabolic and Cardiovascular Changes in Cases with Acromegaly after Regular Short-Term Exercise

Hatipoglu E., Ikitimur B., Topsakal N., Atilgan O. E., ÇAMLIGÜNEY A. F., Niyazoglu M., et al.
ENDOCRINE REVIEWS , cilt.35, sa.3, 2014 (SCI-Expanded, Scopus)

198. INTRAVENOUS ILOPROST TREATMENT SIDE EFFECT PROFILE IN PATIENTS WITH DIGITALULCERS DUE TO SYSTEMIC SCLEROSIS

Ugurlu S., Cevirgen D., Yalcin B.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.32, sa.2, 2014 (SCI-Expanded, Scopus)

199. Interferon alpha-associated depression in patients with Behçet's syndrome: A prospective controlled study

Keskin Y., Seyahi E., Poyraz C., Ugurlu S., Ozyazgan Y., Yazici H.
Clinical and Experimental Rheumatology , cilt.32, 2014 (SCI-Expanded, Scopus)

200. Colchicine in behçet syndrome: A longterm survey of patients in a controlled trial

Hamuryudan V., Hatemi G., Tascilar K., Yurdakul S., Mat C., Ozyazgan Y., et al.
Journal of Rheumatology , cilt.41, sa.4, ss.735-738, 2014 (SCI-Expanded, Scopus)

201. The Clinical Course of Acute Deep Vein Thrombosis of the Legs in Behcet's Syndrome

Ozguler Y., Melikoglu M., Ugurlu S., Cetinkaya F., Tascilar E. K., Seyahi E., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.32, sa.4, 2014 (SCI-Expanded, Scopus)

202. Predictors of Quality Of Life in Behcet's Syndrome

Bozcan S., Ozguler Y., Saygin C., Uzunarslan D., Tascilar E. K., Ugurlu S., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.32, sa.4, 2014 (SCI-Expanded, Scopus)

203. Fever in Behçet's syndrome

Seyahi E., Karaaslan H., Ugurlu S., Yazici H.
Clinical and Experimental Rheumatology , cilt.31, 2013 (SCI-Expanded, Scopus)

204. Aortic and coronary calcifications in Takayasu arteritis

Seyahi E., Ucgul A., Olgun D. C., Ugurlu S., Akman C., Tutar O., et al.
Seminars in Arthritis and Rheumatism , cilt.43, sa.1, ss.96-104, 2013 (SCI-Expanded, Scopus)

205. FATIGUE IS AN IMPORTANT PROBLEM IN PATIENTS WITH BEHCET'S SYNDROME

Buyuktas D., Hatemi G., Findikoglu S. Y., Tascilar K., Ugurlu S., Yurdakul S.
ANNALS OF THE RHEUMATIC DISEASES , cilt.71, ss.225, 2013 (SCI-Expanded, Scopus)

206. Clinical follow-up of neuro-Behcet syndrome patients treated with infliximab

Zeydan B., Demirci N. O., Uygunoglu U., Seyahi E., UĞURLU S., Saip S., et al.
JOURNAL OF NEUROLOGY , cilt.260, 2013 (SCI-Expanded)

207. VENOUS CLAUDICATION IS A SEVERE AND FREQUENT SYMPTOM IN BEHCET'S SYNDROME

Ugurlu S., Seyahi E., Oktay V., Yigit Z., Kucukoglu S., Yazici H.
ANNALS OF THE RHEUMATIC DISEASES , cilt.72, ss.641, 2013 (SCI-Expanded, Scopus)

208. ERYTHEMA OVER THE JOINT MAY HELP TO DISTINGUISH FAMILIAL MEDITERRANEAN FEVER FROM OTHER RHEUMATOLOGIC CONDITIONS

Ugurlu S., Mehmedali F., Nalci F., Gurbuz A., Canbay B., Sengul Y., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.71, ss.287, 2013 (SCI-Expanded, Scopus)

209. INFLIXIMAB FOR SIGHT-THREATENING AND REFRACTORY UVEITIS OF BEHCET'S SYNDROME

Hamuryudan V., Hatemi G., Ozyazgan Y., Ucar D., Yurdakul S., Seyahi E., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.72, ss.488, 2013 (SCI-Expanded, Scopus)

210. A CT EVALUATION OF PULMONARY AND CARDIAC LESIONS IN BEHCET'S SYNDROME PATIENTS WITHOUT PULMONARY SYMPTOMS

Seyahi E., Olgun D. C., Ugurlu S., Hanci I., Takahashi R., Yazici H.
ANNALS OF THE RHEUMATIC DISEASES , cilt.72, ss.541, 2013 (SCI-Expanded, Scopus)

211. MODERATE/SEVERE DISEASE ACTIVITY VS LOW DISEASE ACTIVITY/REMISSION: PATIENT CHARACTERISTICS AND DIFFERENCES AMONG PATIENTS FROM UNITED STATES AND TURKEY

Inanc N., Hatemi G., Simsek I., Ozen G., Tascilar K., Ugurlu S., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.72, ss.602-603, 2013 (SCI-Expanded, Scopus)

212. AN OUTCOME SURVEY OF 40 PATIENTS WITH BUDD-CHIARI SYNDROME DUE TO BEKET'S SYNDROME FOLLOWED BY A SINGLE CENTER

Caglar E., Ugurlu S., Seyahi E., Kantarci F., Sonsuz A., Yurdakul S., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.72, ss.641-642, 2013 (SCI-Expanded, Scopus)

213. Targeted resequencing implicates the familial Mediterranean fever gene MEFV and the toll-like receptor 4 gene TLR4 in Behcet disease

Kirino Y., Zhou Q., Ishigatsubo Y., Mizuki N., Tugal-Tutkun I., Seyahi E., et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA , cilt.110, sa.20, ss.8134-8139, 2013 (SCI-Expanded, Scopus)

214. Lectin-like oxidised LDL receptor-1 as a marker of endothelial dysfunction in Behcet's disease

Ozyazgan S., Uzun H., Onal B., Tuzcu A., Ugurlu S., Andican G.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.31, sa.3, 2013 (SCI-Expanded, Scopus)

215. Behçet syndrome: Is it one condition?

Yazici H., Ugurlu S., Seyahi E.
Clinical Reviews in Allergy and Immunology , cilt.43, sa.3, ss.275-280, 2012 (SCI-Expanded, Scopus)

216. Nonalcoholic Fatty Liver Disease and Familial Mediterranean Fever: Are They Related?

Sarkis C., Caglar E., Ugurlu S., Cetinkaya E., Tekin N., ARSLAN M., et al.
SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO , cilt.140, ss.589-594, 2012 (SCI-Expanded, Scopus) Creative Commons License

217. PREVALANCE OF ASTHMA AND ALLERGIC DISEASES IN MID-ANATOLIA

ARSLAN S., Ugurlu S., DEMİREL Y., Can G.
NOBEL MEDICUS , cilt.8, sa.1, ss.30-34, 2012 (SCI-Expanded, Scopus)

218. Canakinumab in a patient with juvenile Behçet's syndrome with refractory eye disease

Ugurlu S., Ucar D., Seyahi E., Hatemi G., Yurdakul S.
Annals of the Rheumatic Diseases , cilt.71, sa.9, ss.1591-1592, 2012 (SCI-Expanded, Scopus)

219. Anti - saccharomyces cerevisiae (asca) and anti - neu trophil cytoplasmic (anca) antibodies are not increas ed in takayasu arteritis

Ozbakir F., UĞURLU S., ÇELİK A. F., SEYAHİ E.
Acta Reumatologica Portuguesa , cilt.36, sa.1, ss.20-23, 2011 (SCI-Expanded, Scopus)

220. The disease presentation and outcome in juvenile Behcet's syndrome

Seyahi E., Ozdogan H., Ozyazgan Y., Ugurlu S., Ozguler Y., Mat C., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.29, sa.2, ss.387-388, 2011 (SCI-Expanded, Scopus)

221. ANTI-SACCHAROMYCES CEREVISIAE [ASCA] AND ANTI-NEUTROPHIL CYTOPLASMIC [ANCA] ANTIBODIES ARE NOT INCREASED IN TAKAYASU ARTERITIS

Ozbakir F., Ugurlu S., Çelik A. B., Seyahi E.
ACTA REUMATOLOGICA PORTUGUESA , cilt.36, sa.1, ss.20-23, 2011 (SCI-Expanded, Scopus)

222. Serum Levels of Mannan-Binding Lectin in Patients with Crimean-Congo Hemorrhagic Fever

ENGİN A., Ugurlu S., Caglar E., ÖZTOP A. Y., Inan D., ELALDI N., et al.
VECTOR-BORNE AND ZOONOTIC DISEASES , cilt.10, sa.10, ss.1037-1041, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

223. Differences in the body composition and biochemistry in women grouped as normal-weight, overweight and obese according to body mass index and their relation with cardiometabolic risk

Ozenoglu A., Ugurlu S., Can G., Sarkis C., DEMİREL Y.
CENTRAL EUROPEAN JOURNAL OF MEDICINE , cilt.5, sa.6, ss.724-732, 2010 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

224. EYE DISEASE IN JUVENILE PATIENTS WITH BEHCET'S SYNDROME

Ozyazgan Y., Seyahi E., Sarica A., Ugurlu S., Hatemi G., Yurdakul S., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.28, sa.4, 2010 (SCI-Expanded, Scopus)

225. WORK DISABILITY IN BEHCET'S SYNDROME

Hatemi G., Hamuryudan V., Tascilar K., Ugurlu S., Yazici H.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.28, sa.4, 2010 (SCI-Expanded, Scopus)

226. COLCHICINE DOES NOT DECREASE THE NEED FOR IMMUNOSUPPRESSIVE USE AT LONG TERM IN BEHCET'S SYNDROME (BS)

Hamuryudan V., Hatemi G., Yurdakul S., Tascilar K., Mat C., Ozyazgan Y., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.28, sa.4, 2010 (SCI-Expanded, Scopus)

227. ANTI-TNF THERAPY IN SEVERE UVEITIS OF BEHCET'S SYNDROME: REPORT OF 27 PATIENTS

Ugurlu S., Hamuryudan V., Ozyazgan Y., Seyahi E., Hatemi G., Yurdakul S., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.28, sa.4, 2010 (SCI-Expanded, Scopus)

228. THE ASSOCIATION BETWEEN PLASMA D-DIMER LEVELS AND COMMUNITY-ACQUIRED PNEUMONIA

ARSLAN S., Ugurlu S., Bulut G., Akkurt I.
CLINICS , cilt.65, sa.6, ss.593-597, 2010 (SCI-Expanded, Scopus)

229. MUSHROOM POISONING: RETROSPECTIVE ANALYSIS OF 294 CASES

Eren S. H., DEMİREL Y., Ugurlu S., KORKMAZ İ., Aktas C., Kukul Guven F. M.
CLINICS , cilt.65, sa.5, ss.491-496, 2010 (SCI-Expanded, Scopus)

230. AUTOANTIBODY FREQUENCY IN CELIAC DISEASE

Caglar E., Ugurlu S., Ozenoglu A., Can G., Kadioglu P., Dobrucali A. M.
CLINICS , cilt.64, sa.12, ss.1195-1200, 2009 (SCI-Expanded, Scopus) Creative Commons License

231. METABOLIC DISTURBANCES ARISING OUT OF PSYCHIATRIC PHARMACOTHERAPIES AND THE IMPORTANCE OF DIETETIC INTERVENTION IN ITS TREATMENT

Ozenoglu A., Ugurlu S., Can G., Eker E., Elmacioglu F.
NOBEL MEDICUS , cilt.5, ss.36-44, 2009 (SCI-Expanded, Scopus)

232. Alterations in body weight and biochemistry in patient treated with different psychotropic drugs in a clinic in Istanbul

Ozenoglu A., Ugurlu S., Balci H., Can G., Elmacioglu F., DEMIREL Y., et al.
MEDICINSKI GLASNIK , cilt.6, sa.2, ss.197-202, 2009 (SCI-Expanded, Scopus)

233. Intimamedia thickening in patients with familial Mediterranean fever

Ugurlu S., Seyahi E., Cetinkaya F., Ozbakr F., Balci H., Ozdogan H.
RHEUMATOLOGY , cilt.48, sa.8, ss.911-915, 2009 (SCI-Expanded, Scopus)

234. Çölyak hastalığında parietal hücre antikoru sıklığı.

CAGLAR E., UĞURLU S., DOBRUCALI A. M.
Cumhuriyet Tıp Derg , cilt.31, ss.41-44, 2009 (Hakemli Dergi)

235. FAMILIAL MEDITERRANEAN FEVER AND MULTIPLE SCLEROSIS: A CASE REPORT

Ugurlu S., BOLAYIR E., CANDAN F., Gumus C.
ACTA REUMATOLOGICA PORTUGUESA , cilt.34, sa.1, ss.117-119, 2009 (SCI-Expanded, Scopus)

236. Reference values of body composition for adult females who are classified as normal weight, overweight or obese according to body mass index

Ozenoglu A., UĞURLU S., CAN G., Hatemi H.
Endocrine Regulations , cilt.43, sa.1, ss.29-37, 2009 (Scopus)

237. Atherosclerosis in Behcet's syndrome

Seyahi E., Ugurlu S., Cumali R., Balci H., Ozdemir O., Melikoglu M., et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM , cilt.38, sa.1, ss.1-12, 2008 (SCI-Expanded, Scopus)

238. LARGE VESSEL INVOLVEMENT IN BEHCET'S SYNDROME: A RETROSPECTIVE SURVEY

Melikoglu M., Ugurlu S., Tascilar K., Caglar F., Seyahi F., Hamuryudan V., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.26, sa.4, 2008 (SCI-Expanded, Scopus)

239. Prevalence of angina, myocardial infarction and intermittent claudication assessed by Rose Questionnaire among patients with Behcet's syndrome

Ugurlu S., Seyahi E., YAZICI H.
RHEUMATOLOGY , cilt.47, sa.4, ss.472-475, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

240. Features related to other autoinflammatory diseases are frequent among FMF patients

Ozdogan H., Hatemi G., Kasapcopur O., Akcam Y., Ugurlu S., Celik S.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.26, sa.2, ss.193, 2008 (SCI-Expanded, Scopus)

241. Endolaparoscopic approach in the management of gastroesophageal reflux disease: An experimental study in pigs

Sari Y. S., Koc O., Tunali V., Erkan E., Uzum G., Sayilgan C., et al.
JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES , cilt.17, sa.5, ss.639-644, 2007 (SCI-Expanded, Scopus)

242. The effect of a fiber rich dietary product used for the dietary treatment of adult obese women on some biochemical parameters and anthropometric measurements

Ozenoglu A., Ugurlu S., Balci H., Can G., Hatemi H.
ACTA ENDOCRINOLOGICA-BUCHAREST , cilt.3, sa.3, ss.315-322, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

243. Nutritional approach to metabolic changes arising out of schizophrenia therapy: Case report

Ozenoglu A., Ugurlu S., Balci H., Eker E.
INTERNAL MEDICINE , cilt.46, sa.15, ss.1213-1218, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

244. Investigation of microalbuminuria in nondiabetic, normotensive obese women.

Yesim T. E., Ugurlu S., Caglar E., Balci H., Ucgul A., Sarkis C., et al.
Internal medicine (Tokyo, Japan) , cilt.46, sa.24, ss.1963-5, 2007 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

245. Treatment options in colchicine resistant familial Mediterranean fever patients: Thalidomide and etanercept as adjunctive agents

Seyahi E., Ozdogan H., Celik S., Ugurlu S., Yazici H.
Clinical and Experimental Rheumatology , cilt.24, 2006 (SCI-Expanded, Scopus)

246. Atherosclerosis in Takayasu arteritis

Seyahi E., Ugurlu S., Cumali R., Balci H., Seyahi N., Yurdakul S., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.65, sa.9, ss.1202-1207, 2006 (SCI-Expanded, Scopus) Creative Commons License

247. Anti-Saccharomyces cerevisiae antibodies (ASCA) in Behcet's syndrome

Fresko İ., Ugurlu S., Ozbakir F., Celik A. F., Yurdakul S., Hamuryudan V., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.23, sa.4, 2005 (SCI-Expanded, Scopus)

248. Benzen ve toluene gibi uçucuların sık kullanıldığı iş yeri koşullarında tutulan ratların kan parametreleri ve canlı ağırlıklarında gözlenen değişiklikler.

Altunçul V., Uğurlu S., OR M. E.
Bornova Vet. Kont. Araşt. Enst. Derg.. , cilt.27, sa.41, ss.15-18, 2002 (Hakemli Dergi)

249. Tiner inhalasyonunun erkek sıçanlarda solunum sistemine, diğer hayati organlara, hareket sistemine ve davranışlara etkileri

Zor E., Saygı A., Baloğlu H., Öztek I., Uğurlu S., ERÇAĞ E., et al.
The MEdical Bulletin of Heybeliada , cilt.3, sa.2, ss.10-16, 1997 (Hakemli Dergi)

250. Broyler yemlerine katılan antibiyotiklerin ince bağırsak üzerine histolojik etkileri.

DAĞLIOĞLU S., ALP M., ARMUTAK A., FIRAT U. B., UĞURLU S., ÇÖREKÇİ İ., et al.
İstanbul Üniv. Vet. Fak. Derg. , cilt.20, ss.327-340, 1994 (TRDizin)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 76

1. Identification of a splice variant in PSMB10 gene in a multiply affected family with undiagnosed autoinflammatory syndrome

Gecgel M., Bulbul A., Sigli D., ONAT U. İ., UĞURLU S., Tahir Turanlı E.
56th Annual Conference of the European-Society-of-Human-Genetics (ESHG), Glasgow, İngiltere, 10 - 13 Haziran 2023, ss.175, (Özet Bildiri)

2. Candidate Gene Search For Autosomal Dominant Behcet's Disease Through Whole Exome Sequencing

Ugurlu S., Turan G., Karacan I., Dasdemir S., Seven M., Duz M. B., et al.
51st Conference of the European-Society-of-Human-Genetics (ESHG) in conjunction with the European Meeting on Psychosocial Aspects of Genetics (EMPAG), Milan, İtalya, 16 - 19 Haziran 2018, cilt.27, ss.936, (Özet Bildiri)

3. Effect of Aerobic Exercise With Rhythm On Patients With Fibromyalgia

ÇİVİ KARAASLAN T., ÇİÇEK A., TARAKCI E., UĞURLU S.
International Health Sciences and Management Conference (IHMC 2019), İstanbul, Türkiye, 20 - 23 Haziran 2019, ss.1, (Tam Metin Bildiri)

4. INVESTIGATION OF PHYSICAL ACTIVITY LEVELS OF PATIENTS WITH BEHCET'S DISEASE

Uzun N., Tarakci E., ARMAN N., Ugurlu S.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1062, (Özet Bildiri)

5. IN A FAMILIAL MEDITERRANEAN FEVER PREVALENT REGION, ARE FAMILIAL MEDITERRANEAN FEVER AND BEHCET'S DISEASE ASSOCIATED?

ALPARSLAN Ö., Egeli B. H., DEMİREL Y., UĞURLU S.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.2006, (Özet Bildiri)

6. ANAKINRA TREATMENT IN RECURRENT PERICARDITIS: SINGLE CENTER EXPERIENCE

TOKER DİNCER Z., Corbali O., UĞURLU S., Ozdogan H.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1004-1005, (Özet Bildiri)

7. MYCOPHENOLATE MOFETIL IN THE TREATMENT OF MAJOR ORGAN INVOLVEMENT OF PATIENTS WITH BEHCET'S SYNDROME

ESATOĞLU S. N., Cemre E., HAMURYUDAN V., ÖZYAZGAN Y., UÇAR D., KUTLUBAY Z., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.820, (Özet Bildiri)

8. RETROPERITONEAL FIBROSIS- A SINGLE CENTER EXPERIENCE

ÖZTAŞ M., Cemre E., Atun I., DEMİRDAĞ Ç., UĞURLU S.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.2011-2012, (Özet Bildiri)

9. THE IMPACT OF AGING ON FAMILIAL MEDITERRANEAN FEVER PATIENTS

Aydin O., UĞURLU S., Egeli B. H., Soykut A. E., DEMİR YILMAZ D., Ozdogan H.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.576-577, (Özet Bildiri)

10. INITIAL MANIFESTATIONS AND OUTCOME OF PATIENTS WITH INCOMPLETE BEHCET'S SYNDROME

ESATOĞLU S. N., BİLGİN S., SULU C., HAMURYUDAN V., KUTLUBAY Z., UĞURLU S., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.428, (Özet Bildiri)

11. COMPARISON OF FMF PATIENTS WITH AGE OF ONSET BEFORE 20 VERSUS 40 YEARS AND OVER

Aydin O., UĞURLU S., Ozdogan H.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.586, (Özet Bildiri)

12. RITUXIMAB THERAPY IN LUPUS NEPHRITIS RESISTANT TO CONVENTIONAL THERAPY - A SINGLE CENTER EXPERIENCE (CASE SERIES)

YURTTAŞ B., Egeli B. H., UĞURLU S.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1707, (Özet Bildiri)

13. ANALYSIS OF NEW REFERRALS TO A SPECIALIST UK ADULT AUTOINFLAMMATORY DISEASE SERVICE

UĞURLU S., Hawkins P. N., Papadopoulou C., Rezk T., Rowczenio D., Lachmann H. J.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1005-1006, (Özet Bildiri)

14. 10 YEAR PROGNOSIS OF PATIENTS DIAGNOSED WITH FAMILIAL MEDITERRANEAN FEVER

Egeli B. H., Soykut A. E., Ergezen B., UĞURLU S.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.567, (Özet Bildiri)

15. A DECLINING TREND IN FREQUENCY OF SECONDARY AMYLOIDOSIS IN BEHCET'S SYNDROME

Esatoglu S. N., Hatemi G., Karatemiz G., Ozguler Y., Yurdakul S., Hamuryudan V., et al.
19th International Vasculitis and ANCA Workshop, Pennsylvania, Amerika Birleşik Devletleri, 7 - 10 Nisan 2019, cilt.58, (Özet Bildiri)

16. FACTORS ASSOCIATED WITH DAMAGE PROGRESSION IN BEHCET'S SYNDROME UVEITIS

Ozyazgan Y., Ucar D., Erdogan M., Ozguler Y., Hatemi G., Yurdakul S., et al.
19th International Vasculitis and ANCA Workshop, Pennsylvania, Amerika Birleşik Devletleri, 7 - 10 Nisan 2019, cilt.58, ss.107, (Özet Bildiri)

17. INTERFERON-ALPHA FOR THE MANAGEMENT OF LOWER EXTREMITY DEEP VEIN THROMBOSIS IN BEHCET'S SYNDROME: A CASE SERIES

Ozguler Y., Hatemi G., Cetinkaya F., Tascilar K., Ugurlu S., Seyahi E., et al.
19th International Vasculitis and ANCA Workshop, Pennsylvania, Amerika Birleşik Devletleri, 7 - 10 Nisan 2019, cilt.58, (Özet Bildiri)

18. ANAKINRA TREATMENT IN REFRACTORY CASES OF ADULT-ONSET STILL DISEASE: CASE SERIES

Ugurlu S., Yurttas B., Guzelant G., Ergezen B., Ozdogan H.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1164, (Özet Bildiri)

19. THE ASSESSMENT OF IMAGERY ABILITY IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER

Alikaj A., Buyukaslan A., Ugurlu S., Dilek B.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1852, (Özet Bildiri)

20. AN UPDATE ON PULMONARY ARTERY INVOLVEMENT IN BEHCET'S SYNDROME: MORE PULMONARY ARTERY THROMBOTIC DISEASE AND A BETTER OUTCOME

Ozguler Y., Dincses E., Bakan S., Hatemi G., Melikoglu M., Ugurlu S., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1118, (Özet Bildiri)

21. LONG TERM FOLLOW-UP OF BEHCET'S SYNDROME PATIENTS TREATED WITH CYCLOPHOSPHAMIDE

Gurcan M., Esatoglu S. N., Hamuryudan V., SAYGIN C., SAYGIN D., Ugurlu S., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1492-1493, (Özet Bildiri)

22. CANAKINUMAB TREATMENT IN ADULT-ONSET STILL'S DISEASE: CASE SERIES

Ugurlu S., Guzelant G., Yurttas B., Ergezen B., Dalkilic E., Kasifoglu T., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.514, (Özet Bildiri)

23. ANAKINRA TREATMENT IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER: A SINGLE-CENTRE EXPERIENCE

Ergezen B., Ugurlu S., Ozdogan H.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.504-505, (Özet Bildiri)

24. Does Co-morbidity with Familial Mediterranean Fever change the course of Multiple Sclerosis?

Siva A., Tutuncu M., Uygunoglu U., Erdogan M., Ugurlu S., Ozcan B., et al.
70th Annual Meeting of the American-Academy-of-Neurology (AAN), Los-Angeles, Şili, 21 - 27 Nisan 2018, cilt.90, (Özet Bildiri)

25. Bagel Sign in neuro-Behcet's Syndrome

Uygunoglu U., Zeydan B., Ozguler Y., Ugurlu S., Seyahi E., Kocer N., et al.
70th Annual Meeting of the American-Academy-of-Neurology (AAN), Los-Angeles, Şili, 21 - 27 Nisan 2018, cilt.90, (Özet Bildiri)

26. C-Reactive Protein and Serum Amyloid a in Sepsis, Acute Appendicitis and Familial Mediterranean Fever

SELVİ O., UĞURLU S., BOLAYIRLI İ. M., ÖZDOĞAN A. H., KASAPÇOPUR Ö.
2017 ACR/ARHP Annual Meeting, Chıcago, Amerika Birleşik Devletleri, 3 - 09 Kasım 2017, ss.69, (Tam Metin Bildiri)

27. TAPERING TNF INHIBITORS IN RHEUMATOID ARTHRITIS: A RETROSPECTIVE STUDY

Hacioglu A., Hatemi G., Esatoglu S. N., Ozguler Y., Ugurlu S., Seyahi E., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1186, (Özet Bildiri)

28. ANTI-INTERLEUKIN 1 THERAPY IN FMF AMYLOIDOSIS: A SINGLE CENTER EXPERIENCE (CASE SERIES)

Ugurlu S., Ergezen B., Hacioglu A., Ozdogan H.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.412, (Özet Bildiri)

29. ANTI TNF-ALPHA THERAPY WOULD BE LIFESAVING IN DEFICIENCY OF ADENOSINE DEAMINASE-2

Sahin S., Adrovic A., Barut K., Ugurlu S., Turanli E. T., Ozdogan H., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1402-1403, (Özet Bildiri)

30. PROBLEMS IN THE DIAGNOSIS OF FAMILIAL MEDITERRANEAN FEVER IN TURKEY

Erdogan M., Ozguler Y., Karatemiz G., Esatoglu S. N., Guzelant G., Dinces E., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.719-720, (Özet Bildiri)

31. ASSOCIATED INFLAMMATORY SYNDROMES IN TAKAYASU'S ARTERITIS: MANY FACES OF A DISEASE

Esatoglu S. N., Celik A. M., Ucar D., Celik A. F., Ugurlu S., Hatemi G., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.618, (Özet Bildiri)

32. AN OUTCOME SURVEY OF 100 PATIENTS WITH CEREBRAL VENOUS SINUS THROMBOSIS DUE TO BEHET'S SYNDROME FOLLOWED UP AT A SINGLE, DEDICATED CENTER

Kurt E. A., Ozguler Y., Kocer N., Ucar D., Uygunoglu U., Islak C., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.603, (Özet Bildiri)

33. TREX 1 MUTATION IN THE MEMBERS OF A FAMILY WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND ANTIPHOSPHOLIPID SYNDROME

Ugurlu S., Karacan I., Ozdogan H., Tolun A., Turanli E. T.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1101, (Özet Bildiri)

34. CAN WE DIFFERENTIATE TAKAYASU'S ARTERITIS FROM ATHEROSCLEROSIS USING CAROTID ARTERY DOPPLER USG?

Seyahi E., Esatoglu S. N., Ugurlu S., Keskin F. E., CETINKAYA F., Melikoglu M., et al.
18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.46-47, (Özet Bildiri)

35. RITUXIMAB FOR ANCA ASSOCIATED VASCULITIS REFRACTORY TO CONVENTIONAL TREATMENT: A RETROSPECTIVE STUDY ON 25 PATIENTS

Ayan G., Ugurlu S., Hatemi G., Seyahi E., Melikoglu M., Fresko I., et al.
18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.153-154, (Özet Bildiri)

36. ASSOCIATED INFLAMMATORY DISEASES IN TAKAYASU'S ARTERITIS: THE MANY FACES OF A DISEASE

Esatoglu S. N., Celik A. M., Ucar D., Ugurlu S., Hatemi G., Hamuryudan V., et al.
18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.47, (Özet Bildiri)

37. How to Differentiate Longitudinally Extensive Transverse Myelitis of Neuro-Behcet Syndrome from Neuromyelitis Optica Spectrum Disorders?

Siva A., Uygunoglu U., Zeydan B., Tutuncu M., Ozguler Y., Seyahi E., et al.
9th Congress of the Pan-Asian-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (PACTRIMS), Bangkok, Tayland, 27 - 29 Ekim 2016, cilt.23, ss.342, (Özet Bildiri)

38. ANAKINRA TREATMENT IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER: A SINGLE-CENTER EXPERIENCE

Ugurlu S., Ozdogan H., Ergezen B.
Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, cilt.75, ss.622, (Özet Bildiri)

39. DISCREPANCY BETWEEN PATIENTS AND PHYSICIANS ON GLOBAL DISEASE ASSESSMENT OF RA AND ITS DETERMINANTS: AN ANALYSIS FROM THE TRAV COHORT

Tascilar K., Hatemi G., Inanc N., Simsek I., Swearingen C., Cinar M., et al.
Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, cilt.75, ss.884, (Özet Bildiri)

40. ANTI-INTERLEUKIN-1 THERAPY IN FAMILIAL MEDITERRANEAN FEVER AMYLOIDOSIS: A SINGLE CENTER EXPERIENCE

Ozdogan H., Ugurlu S., Hacioglu A., Ergezen B.
Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, cilt.75, ss.1212, (Özet Bildiri)

41. CAN WE DIFFERENTIATE TAKAYASU ARTERITIS FROM ATHEROSCLEROSIS USING CAROTID AND FEMORAL ARTERY DOPPLER USG?

Ugurlu S., Cetinkaya F., Keskin F. E., Melikoglu M., Hamuryudan V., Fresko I., et al.
Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, cilt.75, ss.799-800, (Özet Bildiri)

42. THE DISEASE ASSOCIATIONS OF TAKAYASU'S ARTERITIS

Esatoglu S. N., Celik A. M., Ucar D., Celik A. F., Ugurlu S., Hatemi G., et al.
Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, cilt.75, ss.1100-1101, (Özet Bildiri)

43. Spinal Cord Involvement in Neuro-Behcet Syndrome

Zeydan B., Uygunoglu U., Seyahi E., Ugurlu S., Saip S., Kantarci O., et al.
68th Annual Meeting of the American-Academy-of-Neurology (AAN), Vancouver, Kanada, 15 - 21 Nisan 2016, cilt.86, (Özet Bildiri)

44. Metabolic and cardiovascular changes in cases with acromegaly after regular short-term exercise (SUN-0594)

Hatipoğlu E., İKİTİMUR B., Topsakal N., Erkut Atılgan O., Çamlıgüney A. F., Niyazioğlu M., et al.
Endocrine Society's 96th Annual Meeting and Expo, Chicago, Amerika Birleşik Devletleri, 21 - 24 Ağustos 2014, cilt.35, sa.3, ss.594, (Özet Bildiri)

45. ANTI-TNF TREATMENT FOR REFRACTORY VASCULAR INVOLVEMENT OF BEHCET'S SYNDROME: A REPORT OF 16 PATIENTS

Hamuryudan V., Seyahi E., Melikoglu M., Ugurlu S., Hatemi G., Yurdakul S., et al.
15th Annual European Congress of Rheumatology (EULAR), Paris, Fransa, 11 - 14 Haziran 2014, cilt.73, ss.1005, (Özet Bildiri)

46. TOCILIZUMAB (TCZ) IN THE TREATMENT OF AA AMYLOIDOSIS IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER

Ozdogan H., Ugurlu S., Hacioglu A., Adibnia Y., Hamuryudan V.
15th Annual European Congress of Rheumatology (EULAR), Paris, Fransa, 11 - 14 Haziran 2014, cilt.73, ss.313, (Özet Bildiri)

47. CANAKINUMAB THERAPY IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER

Ugurlu S., Seyahi E., Hatemi G., Hacioglu A., Akkoc N. F., Ozdogan H.
15th Annual European Congress of Rheumatology (EULAR), Paris, Fransa, 11 - 14 Haziran 2014, cilt.73, ss.320-321, (Özet Bildiri)

48. A subgroup of neuro-Behcet syndrome: intracranial arterial involvement

Zeydan B., Uygunoglu U., Tutuncu M., YALÇINKAYA C., ALTINTAŞ A. T., UĞURLU S., et al.
Joint Congress of European Neurology, İstanbul, Türkiye, 31 Mayıs - 03 Haziran 2014, cilt.261, (Özet Bildiri)

49. CONCOMITANT TRANSVERSE MYELITIS AND GUILLAIN-BARRE SYNDROME AFTER ADALIMUMAB THERAPY IN A CASE WITH ANKYLOSING SPONDYLITIS

Ugurlu S., Saygin C., Uzunaslan D., Tascilar K., Ince B., Saip S.
European Workshop for Rheumatology Research, Lisbon, Portekiz, 20 - 22 Şubat 2014, cilt.73, (Özet Bildiri)

50. Venous Claudication Is A Severe and Frequent Symptom In BEHCET'S Syndrome

Ugurlu S., Seyahi E., Oktay V., Yigit Z., Kucukoglu S., Yazici H.
77th Annual Meeting of the American-College-of-Rheumatology / 48th Annual Meeting of the Association-of-Rheumatology-Health-Professionals, California, Amerika Birleşik Devletleri, 25 - 30 Ekim 2013, cilt.65, (Özet Bildiri)

51. Canakinumab In Patients With FMF

Ugurlu S., Seyahi E., Hatemi G., Hacioglu A., Ozdogan H.
77th Annual Meeting of the American-College-of-Rheumatology (ACR) / 48th Annual Meeting of the Association-of-Rheumatology-Health-Professionals (ARHP), California, Amerika Birleşik Devletleri, 25 - 30 Ekim 2013, cilt.65, (Özet Bildiri)

52. An Outcome Survey Of 40 Patients With Budd-Chiari Syndrome Due To BEHCET'S Syndrome Followed By A Single Center

Seyahi E., Ugurlu S., Caglar E., Kantarci F., Sonsuz A., Yurdakul S., et al.
77th Annual Meeting of the American-College-of-Rheumatology / 48th Annual Meeting of the Association-of-Rheumatology-Health-Professionals, California, Amerika Birleşik Devletleri, 25 - 30 Ekim 2013, cilt.65, (Özet Bildiri)

53. Infliximab For Sight-Threatening and Refractory Uveitis Of Behcet's Syndrome

Hamuryudan V., Hatemi G., Ozyazgan Y., Ucar D., Yurdakul S., Seyahi E., et al.
77th Annual Meeting of the American-College-of-Rheumatology / 48th Annual Meeting of the Association-of-Rheumatology-Health-Professionals, California, Amerika Birleşik Devletleri, 25 - 30 Ekim 2013, cilt.65, (Özet Bildiri)

54. A CT Evaluation Of Pulmonary and Cardiac Lesions In BEHCET'S Syndrome Patients Without Pulmonary Symptoms

Seyahi E., Olgun D. C., Ugurlu S., Hanci I., Takahashi R., Yazici H.
77th Annual Meeting of the American-College-of-Rheumatology / 48th Annual Meeting of the Association-of-Rheumatology-Health-Professionals, California, Amerika Birleşik Devletleri, 25 - 30 Ekim 2013, cilt.65, (Özet Bildiri)

55. Infliximab Treatment in Neuro-Behcet Disease Unresponsive to Immunosuppressive Treatments: Clinical Assessment of Eleven Patients

Zeydan B., Uygunoglu U., Seyahi E., Ugurlu S., Saipoglu S., Siva A.
65th Annual Meeting of the American-Academy-of-Neurology (AAN), California, Amerika Birleşik Devletleri, 16 - 23 Mart 2013, cilt.80, (Özet Bildiri)

56. Efficacy and Safety of Canakinumab in Adults with Colchicine Resistant Familial Mediterranean Fever

Gul A., Ozdogan H., Erer B., Ugurlu S., Davis N., Sevgi S., et al.
Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP), Washington, Kiribati, 9 - 14 Kasım 2012, cilt.64, (Özet Bildiri)

57. Aortic and Coronary Calcifications in Takayasu Arteritis

Seyahi E., Ucgul A., Ugurlu S., Akman C., Olgun D. C., Yurdakul S., et al.
Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP), Washington, Kiribati, 9 - 14 Kasım 2012, cilt.64, (Özet Bildiri)

58. The Clinical Course of the Acute Deep Vein Thrombosis of the Legs in Behcet's Syndrome.

Ozguler Y., Melikoglu M., Cetinkaya F., Ugurlu S., Seyahi E., Tascilar K., et al.
Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP), Washington, Kiribati, 9 - 14 Kasım 2012, cilt.64, (Özet Bildiri)

59. DO Carriers of A MEFV Mutation Have Any Selective Advantage to A Pathogen Endemic In the Same Geography?

Ugurlu S., ENGİN A., Hatemi G., Ozgon G., Akyayla E., BAKIR M., et al.
75th Annual Scientific Meeting of the American-College-of-Rheumatology/46th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, Illinois, Amerika Birleşik Devletleri, 4 - 09 Kasım 2011, cilt.63, (Özet Bildiri)

60. Some Manifestations Disappear Earlier Than Others in Behcet's Syndrome

Sacli F. S., Seyahi E., Ugurlu S., Ozyazgan Y., Mat C., Yazici H.
75th Annual Scientific Meeting of the American-College-of-Rheumatology/46th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, Illinois, Amerika Birleşik Devletleri, 4 - 09 Kasım 2011, cilt.63, (Özet Bildiri)

61. FOUR NOVEL MEFV GENE MUTATIONS IN A POPULATION WHERE THE PREVALENCE OF CRIMEAN-CONGO HEMORRHAGIC FEVER AND MEFV GENE CARRIER STATUS IS VERY HIGH

Ozgon G., ENGİN A., Hatemi G., Akyayla E., Ugurlu S., BAKIR M., et al.
Conference on Excellence in Rheumatology, İstanbul, Türkiye, 17 - 19 Şubat 2011, cilt.50, (Özet Bildiri) Creative Commons License

62. COLCHICINE DOES NOT DECREASE THE NEED FOR IMMUNOSUPPRESSIVE USE AT LONG TERM IN BEHCET'S SYNDROME

Hamuryudan V., Hatemi G., Yurdakul S., Mat C., Tascilar K., Ozyazgan Y., et al.
Conference on Excellence in Rheumatology, İstanbul, Türkiye, 17 - 19 Şubat 2011, cilt.50, (Özet Bildiri)

63. ANTI-TNF THERAPY IN SEVERE UVEITIS OF BEHCET'S SYNDROME: REPORT OF 27 PATIENTS

Ugurlu S., Hamuryudan V., Ozyazgan Y., Seyahi E., Hatemi G., Yurdakul S., et al.
Conference on Excellence in Rheumatology, İstanbul, Türkiye, 17 - 19 Şubat 2011, cilt.50, (Özet Bildiri)

64. DOES CARRIERSHIP FOR FMF-ASSOCIATED MUTATIONS OFFER ANY ADVANTAGE IN CRIMEAN-CONGO HAEMORRHAGIC FEVER?

Ugurlu S., ENGİN A., Ozgon G., Hatemi G., Akyayla E., BAKIR M., et al.
Conference on Excellence in Rheumatology, İstanbul, Türkiye, 17 - 19 Şubat 2011, cilt.50, (Özet Bildiri)

65. WORK DISABILITY IN BEHCET'S SYNDROME

Hatemi G., Hamuryudan V., Tascilar K., Ugurlu S., Yazici H.
Conference on Excellence in Rheumatology, İstanbul, Türkiye, 17 - 19 Şubat 2011, cilt.50, (Özet Bildiri)

66. THE FREQUENCY OF NEPHROLITHIASIS AMONG PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER

Ozdogan H., Hatemi G., Ugurlu S., Ozguler Y., MASATLIOGLU S., ÇELİK S., et al.
Conference on Excellence in Rheumatology, İstanbul, Türkiye, 17 - 19 Şubat 2011, cilt.50, (Özet Bildiri)

67. PREVALENCE OF FMF AND CHRONIC RENAL FAILURE DUE TO AMYLOIDOSIS AND FREQUENCY OF MEFV MUTATIONS IN ZARA, TURKEY

Ozdogan H., Ugurlu S., Hatemi G., DEMİREL Y., Calli S., OZGON G., et al.
Conference on Excellence in Rheumatology, İstanbul, Türkiye, 17 - 19 Şubat 2011, cilt.50, (Özet Bildiri)

68. Ailevi Akdeniz Ateşinde(AAA) Anti-Saccharomyces cerevisiae(ASCA) antikorları

ÖZBAKIR F., UĞURLU S., SEYAHİ E., ÇELİK A. F., ÖZDOĞAN A. H.
XI. Romatoloji Kongresi, Antalya, Türkiye, 13 - 17 Ekim 2010, cilt.2, sa.2, ss.134, (Tam Metin Bildiri)

69. Subclinical atherosclerosis in familial Mediterranean fever

Ugurlu S., Seyahi E., Cetinkaya F., Ozbakir F., Balci H., Ozdogan H.
72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, San-Francisco, Kostarika, 24 - 29 Ekim 2008, cilt.58, (Özet Bildiri)

70. Large vessel involvement in Behcet's syndrome: A retrospective survery

Melikoglu M., Ugurlu S., Tascilar K., Caglar E., Seyahi E., Hamuryudan V., et al.
72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, San-Francisco, Kostarika, 24 - 29 Ekim 2008, cilt.58, (Özet Bildiri)

71. Behcet's syndrome and the atherosclerotic risk

Seyahi E., Hamuryudan V., Ugurlu S., Balci H., Yurdakul S., Yazici H.
Annual European Congress of Rheumatology (EULAR 2006), Amsterdam, Hollanda, 21 - 24 Haziran 2006, cilt.65, ss.379, (Özet Bildiri)

72. Atherosclerosis in Takayasu arteritis

Seyahi E., Cumali R., Ugurlu S., Balci H., Yurdakul S., Yazici H.
Annual European Congress of Rheumatology, Vienna, Avusturya, 8 - 11 Haziran 2005, cilt.64, ss.270, (Özet Bildiri)

73. The disease presentation and outcome in children with Behcet's syndrome

Seyahi E., Ozdogan H., Yurdakul S., Ugurlu S., Ozyazgan Y., Mat C., et al.
Annual European Congress of Rheumatology, Vienna, Avusturya, 8 - 11 Haziran 2005, cilt.64, ss.270-271, (Özet Bildiri)

74. ASCA (anti-saccharomyces ceirevisiae) antibodies in bs (Behcet's syndrome)

Fresko I., Ugurlu S., Ozbakir F., Celik A., Yurdakul S., Yazici H.
Annual European Congress of Rheumatology, Lisbon, Portekiz, 18 Haziran 2003, cilt.62, ss.209, (Özet Bildiri)

75. Anti-Sacchcaromyces cerevisiae antibodies(ASCA) in Behçet’s

FRESKO İ., UĞURLU S., ÖZBAKIR F., ÇELİK A. F., YURDAKUL S., YAZICI H.
Annual European Congress of Rheumatology. EULAR 2003, Lizbon, Portekiz, 18 - 21 Haziran 2003, cilt.62, sa.1, ss.209, (Özet Bildiri)

76. Broyler yemlerine katılan antibiyotiklerin ince bağırsak üzerine histolojik etkileri.

DAĞLIOĞLU S., ALP M., ARMUTAK A., FIRAT U. B., UĞURLU S., ÇÖREKÇİ İ., et al.
YUTAV 95, Uluslararası Tavukçuluk Kongresi, Türkiye, ss.383-392, (Tam Metin Bildiri)
Metrikler

Yayın

352

Yayın (WoS)

316

Yayın (Scopus)

245

Atıf (WoS)

2743

H-İndeks (WoS)

28

Atıf (Scopus)

2901

H-İndeks (Scopus)

29

Atıf (Scholar)

23

H-İndeks (Scholar)

3

Atıf (TrDizin)

1

H-İndeks (TrDizin)

1

Atıf (Diğer Toplam)

1

Proje

4

Açık Erişim

31
BM Sürdürülebilir Kalkınma Amaçları
SDG 1: AMAÇ 1: YOKSULLUĞA SON
SDG 3: AMAÇ 3: SAĞLIKLI BİREYLER
SDG 12: AMAÇ 12: SORUMLU ÜRETİM VE TÜKETİM
SDG 16: AMAÇ 16: BARIŞ VE ADALET